Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,69,1.09 [1.07-1.12],1.72915981569255e-18,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NFASC,Neurofascin,Inverse variance weighted,69,1.1 [1.07-1.13],9.80555213481666e-14,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MATN3,Matrilin-3,Inverse variance weighted,69,0.92 [0.9-0.95],5.84392116254481e-11,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TLR3,Toll-like receptor 3,Inverse variance weighted,69,1.04 [1.03-1.06],7.36866633157032e-11,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,69,1.1 [1.07-1.14],5.67354487352596e-09,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLXNB2,Plexin-B2,Inverse variance weighted,69,1.09 [1.06-1.12],5.99167774665833e-09,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CTSB,Cathepsin B,Inverse variance weighted,69,0.92 [0.89-0.95],2.10617936959455e-08,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,69,0.93 [0.9-0.95],5.97739149919623e-08,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CHAD,Chondroadherin,Inverse variance weighted,69,0.93 [0.9-0.95],8.17903048003832e-08,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,69,1.08 [1.05-1.11],1.19374360988359e-07,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,69,1.06 [1.04-1.09],1.47603742573045e-07,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDH17,Cadherin-17,Inverse variance weighted,69,1.07 [1.05-1.1],1.73687164164362e-07,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TREH,Trehalase,Inverse variance weighted,69,1.07 [1.04-1.1],4.59360819642832e-07,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CTSO,Cathepsin O,Inverse variance weighted,69,1.08 [1.04-1.11],1.81001445869051e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,69,0.92 [0.89-0.95],1.97581648122542e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NPY,Pro-neuropeptide Y,Inverse variance weighted,69,1.1 [1.06-1.14],2.17326974468014e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,69,1.08 [1.05-1.12],2.26671310588808e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,69,1.06 [1.04-1.09],2.30305805681645e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CES2,Cocaine esterase,Inverse variance weighted,69,1.07 [1.04-1.11],2.81339847511117e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SELE,E-selectin,Inverse variance weighted,69,1.06 [1.03-1.08],3.51736395381707e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,69,1.08 [1.04-1.11],5.12609606677209e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LGALS4,Galectin-4,Inverse variance weighted,69,1.07 [1.04-1.1],5.85056986162849e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GSTA1,Glutathione S-transferase A1,Inverse variance weighted,69,1.08 [1.04-1.12],6.63308205002531e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,Inverse variance weighted,69,1.07 [1.04-1.1],6.74504700075368e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,69,1.07 [1.04-1.1],7.0312716548536e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADIPOQ,Adiponectin,Inverse variance weighted,69,0.93 [0.91-0.96],9.9431777776612e-06,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TPK1,Thiamin pyrophosphokinase 1,Inverse variance weighted,69,0.95 [0.92-0.97],1.05169655055703e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SELPLG,P-selectin glycoprotein ligand 1,Inverse variance weighted,69,1.07 [1.04-1.11],1.13735711129432e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HEPH,Hephaestin,Inverse variance weighted,69,1.05 [1.03-1.08],1.29660531958442e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,UPB1,Beta-ureidopropionase,Inverse variance weighted,69,1.09 [1.05-1.13],1.56450588360413e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,69,1.05 [1.03-1.07],1.57931609693789e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,Inverse variance weighted,69,1.03 [1.02-1.05],1.83656685088317e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IFNGR2,Interferon gamma receptor 2,Inverse variance weighted,69,1.05 [1.03-1.07],1.88698516670289e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FTCD,Formimidoyltransferase-cyclodeaminase,Inverse variance weighted,69,1.07 [1.04-1.1],2.03318960954419e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,69,1.07 [1.04-1.1],2.07933103513386e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ALDH1A1,Retinal dehydrogenase 1,Inverse variance weighted,69,1.06 [1.03-1.09],2.82677776448831e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PYY,Peptide YY,Inverse variance weighted,69,1.07 [1.04-1.1],2.91095552798241e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ASAH2,Neutral ceramidase,Inverse variance weighted,69,1.06 [1.03-1.09],2.99356452161457e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,APOF,Apolipoprotein F,Inverse variance weighted,69,0.92 [0.88-0.96],3.27926581508903e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,Inverse variance weighted,69,0.93 [0.9-0.96],3.64375920283026e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDH1,Cadherin-1,Inverse variance weighted,69,1.05 [1.03-1.08],4.42668921246151e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MAN2B2,Epididymis-specific alpha-mannosidase,Inverse variance weighted,69,1.05 [1.03-1.07],4.45413005309945e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,69,1.06 [1.03-1.1],4.684666828637e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,69,0.93 [0.9-0.96],5.19172492088821e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IGFBP1,Insulin-like growth factor-binding protein 1,Inverse variance weighted,69,0.92 [0.88-0.96],5.78591860895427e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MASP1,Mannan-binding lectin serine protease 1,Inverse variance weighted,69,1.06 [1.03-1.09],6.44478633423651e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,Inverse variance weighted,69,1.07 [1.03-1.1],6.47088828798033e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,69,1.06 [1.03-1.09],7.01690446768119e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AFM,Afamin,Inverse variance weighted,69,1.07 [1.04-1.11],7.47421602418569e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADH1B,All-trans-retinol dehydrogenase,Inverse variance weighted,69,1.06 [1.03-1.09],8.22117086491422e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,OMD,Osteomodulin,Inverse variance weighted,69,0.94 [0.91-0.97],8.98191767534729e-05,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MET,Hepatocyte growth factor receptor,Inverse variance weighted,69,0.93 [0.89-0.96],0.000120255676049639,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IDUA,Alpha-L-iduronidase,Inverse variance weighted,69,1.06 [1.03-1.09],0.000120338487338112,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL11,Eotaxin,Inverse variance weighted,69,1.05 [1.02-1.07],0.000122325364658486,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SGSH,N-sulphoglucosamine sulphohydrolase,Inverse variance weighted,69,1.04 [1.02-1.06],0.000122470827462526,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MME,Neprilysin,Inverse variance weighted,69,1.05 [1.03-1.08],0.000123662202081691,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LPL,Lipoprotein lipase,Inverse variance weighted,69,0.92 [0.88-0.96],0.000124174058446677,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,69,1.06 [1.03-1.09],0.000130157427157682,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BGLAP,Osteocalcin,Inverse variance weighted,69,0.95 [0.93-0.98],0.00013131271025763,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DSCAM,Down syndrome cell adhesion molecule,Inverse variance weighted,69,1.06 [1.03-1.09],0.00014139078621767,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,69,1.04 [1.02-1.07],0.000152305426024867,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,69,1.05 [1.02-1.08],0.00016827702729967,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SHBG,Sex hormone-binding globulin,Inverse variance weighted,69,0.92 [0.89-0.96],0.000173816049474145,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,WIF1,Wnt inhibitory factor 1,Inverse variance weighted,69,0.94 [0.91-0.97],0.00017877489085355,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,69,1.05 [1.03-1.08],0.000181111187951329,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,69,0.95 [0.92-0.97],0.000186836593389702,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,69,1.06 [1.03-1.1],0.000201396619605555,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DCXR,L-xylulose reductase,Inverse variance weighted,69,1.06 [1.03-1.09],0.000203164684826152,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GSTA3,Glutathione S-transferase A3,Inverse variance weighted,69,1.06 [1.03-1.1],0.000215224143971849,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,69,1.06 [1.03-1.09],0.000224675117938553,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,69,1.05 [1.02-1.07],0.000253762854365359,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AMOT,Angiomotin,Inverse variance weighted,69,1.05 [1.02-1.08],0.00025743755588528,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,69,1.05 [1.02-1.08],0.000261164840419479,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,69,1.06 [1.03-1.1],0.000261351210136589,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GDF15,Growth/differentiation factor 15,Inverse variance weighted,69,1.05 [1.02-1.08],0.000261452035262127,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,COL1A1,Collagen alpha-1(I) chain,Inverse variance weighted,69,0.95 [0.92-0.98],0.000265786479085882,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,69,1.06 [1.03-1.09],0.000269764697762413,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,69,1.06 [1.03-1.09],0.000286935055228598,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CTBS,Di-N-acetylchitobiase,Inverse variance weighted,69,1.05 [1.02-1.09],0.00031728141991542,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ACAN,Aggrecan core protein,Inverse variance weighted,69,0.95 [0.92-0.98],0.000341760493940648,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MXRA8,Matrix remodeling-associated protein 8,Inverse variance weighted,69,0.93 [0.89-0.97],0.000387639427151377,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,F13B,Coagulation factor XIII B chain,Inverse variance weighted,69,0.95 [0.92-0.98],0.000388866254571443,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTPRB,Receptor-type tyrosine-protein phosphatase beta,Inverse variance weighted,69,1.05 [1.02-1.08],0.000407386501069725,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,69,1.05 [1.02-1.07],0.000448819435831687,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RTN4R,Reticulon-4 receptor,Inverse variance weighted,69,1.07 [1.03-1.11],0.000463118976216302,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LPO,Lactoperoxidase,Inverse variance weighted,69,1.06 [1.03-1.09],0.00046582933028833,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ANGPTL2,Angiopoietin-related protein 2,Inverse variance weighted,69,1.05 [1.02-1.09],0.000499592079133341,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,REN,Renin,Inverse variance weighted,69,1.05 [1.02-1.07],0.000502296622909605,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CPM,Carboxypeptidase M,Inverse variance weighted,69,1.07 [1.03-1.11],0.00053692613767769,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ANGPTL3,Angiopoietin-related protein 3,Inverse variance weighted,69,0.95 [0.93-0.98],0.000542254019196366,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDHR2,Cadherin-related family member 2,Inverse variance weighted,69,1.06 [1.02-1.09],0.000574166981287331,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CLUL1,Clusterin-like protein 1,Inverse variance weighted,69,0.95 [0.93-0.98],0.00058944843728961,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,Inverse variance weighted,69,1.04 [1.02-1.07],0.000615870703239694,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,69,1.05 [1.02-1.08],0.000641738587783996,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PKD1,Polycystin-1,Inverse variance weighted,69,1.04 [1.02-1.07],0.000642516608767815,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AREG,Amphiregulin,Inverse variance weighted,69,1.05 [1.02-1.09],0.000656871657411947,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HMOX1,Heme oxygenase 1,Inverse variance weighted,69,0.95 [0.92-0.98],0.000669330985683977,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,69,1.04 [1.02-1.07],0.000738285111059514,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RBP5,Retinol-binding protein 5,Inverse variance weighted,69,1.06 [1.02-1.1],0.000744954300998059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SERPINA12,Serpin A12,Inverse variance weighted,69,1.03 [1.01-1.06],0.00080866079337817,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MENT,Protein MENT,Inverse variance weighted,69,0.95 [0.93-0.98],0.000852404273605297,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,69,1.05 [1.02-1.09],0.000885590417438778,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HEG1,Protein HEG homolog 1,Inverse variance weighted,69,1.05 [1.02-1.08],0.000889422483685981,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTS,6-pyruvoyl tetrahydrobiopterin synthase,Inverse variance weighted,69,1.06 [1.02-1.09],0.000904344787005361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SIT1,Signaling threshold-regulating transmembrane adapter 1,Inverse variance weighted,69,1.05 [1.02-1.07],0.000918016184422761,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ITGB2,Integrin beta-2,Inverse variance weighted,69,1.05 [1.02-1.09],0.000937878037091958,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,Inverse variance weighted,69,1.04 [1.02-1.07],0.000943008311130857,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,69,1.05 [1.02-1.08],0.00106946963056123,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KRT8,"Keratin, type II cytoskeletal 8",Inverse variance weighted,69,1.05 [1.02-1.07],0.00110744077580901,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,INHBC,Inhibin beta C chain,Inverse variance weighted,69,1.07 [1.03-1.11],0.00112175362878334,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,69,1.06 [1.02-1.09],0.00113881515753557,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HGF,Hepatocyte growth factor,Inverse variance weighted,69,1.05 [1.02-1.09],0.00114640271076138,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FUOM,Fucose mutarotase,Inverse variance weighted,69,1.06 [1.02-1.09],0.00114699075763743,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PSRC1,Proline/serine-rich coiled-coil protein 1,Inverse variance weighted,69,1.05 [1.02-1.08],0.00122437888985995,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DPP6,Dipeptidyl aminopeptidase-like protein 6,Inverse variance weighted,69,1.05 [1.02-1.09],0.00122504647317552,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ZHX2,Zinc fingers and homeoboxes protein 2,Inverse variance weighted,69,1.04 [1.02-1.06],0.00124687717333257,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GHR,Growth hormone receptor,Inverse variance weighted,69,1.07 [1.02-1.11],0.00139867071424213,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PBLD,Phenazine biosynthesis-like domain-containing protein,Inverse variance weighted,69,1.05 [1.02-1.08],0.00143249708773429,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,69,1.05 [1.02-1.08],0.00155289519603787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MUC13,Mucin-13,Inverse variance weighted,69,1.05 [1.02-1.08],0.00173114171481336,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Inverse variance weighted,69,1.05 [1.02-1.08],0.001750195862011,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,69,0.94 [0.9-0.98],0.00177104452442046,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GUSB,Beta-glucuronidase,Inverse variance weighted,69,1.05 [1.02-1.08],0.00180332152344113,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EZR,Ezrin,Inverse variance weighted,69,1.04 [1.02-1.07],0.00182303146836164,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ACY1,Aminoacylase-1,Inverse variance weighted,69,1.07 [1.03-1.12],0.00183520197540966,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,69,1.04 [1.02-1.07],0.00187008260822351,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL17RB,Interleukin-17 receptor B,Inverse variance weighted,69,0.94 [0.91-0.98],0.00201428646840147,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD101,Immunoglobulin superfamily member 2,Inverse variance weighted,69,1.03 [1.01-1.05],0.00207766910791485,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,APOA4,Apolipoprotein A-IV,Inverse variance weighted,69,1.04 [1.01-1.07],0.00208103497992218,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CFHR4,Complement factor H-related protein 4,Inverse variance weighted,69,0.97 [0.96-0.99],0.00209334300129155,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,69,1.04 [1.01-1.06],0.00213709043431082,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,APOD,Apolipoprotein D,Inverse variance weighted,69,0.94 [0.9-0.98],0.00214029290070079,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AGR3,Anterior gradient protein 3,Inverse variance weighted,69,1.05 [1.02-1.08],0.00223020664818665,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GAS2,Growth arrest-specific protein 2,Inverse variance weighted,69,1.04 [1.01-1.07],0.00224103047684016,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNC,Tenascin,Inverse variance weighted,69,0.96 [0.93-0.98],0.00231660921838702,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GZMB,Granzyme B,Inverse variance weighted,69,1.04 [1.01-1.07],0.00232212563003353,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,Inverse variance weighted,69,1.06 [1.02-1.1],0.00233094394638048,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,APOC1,Apolipoprotein C-I,Inverse variance weighted,69,0.96 [0.93-0.98],0.00234658620136406,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLAT,Tissue-type plasminogen activator,Inverse variance weighted,69,1.05 [1.02-1.08],0.00238039178568767,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CKB,Creatine kinase B-type,Inverse variance weighted,69,0.92 [0.88-0.97],0.00242144432768372,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NCAN,Neurocan core protein,Inverse variance weighted,69,0.96 [0.93-0.98],0.00245853154540185,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,69,1.04 [1.02-1.07],0.00273467676296082,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL15,C-C motif chemokine 15,Inverse variance weighted,69,1.04 [1.01-1.06],0.00274962179002202,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,69,1.03 [1.01-1.05],0.00278100212988544,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KITLG,Kit ligand,Inverse variance weighted,69,0.96 [0.94-0.99],0.00299632516935056,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GSN,Gelsolin,Inverse variance weighted,69,0.95 [0.92-0.98],0.00303843359794843,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VNN1,Pantetheinase,Inverse variance weighted,69,1.05 [1.02-1.08],0.00312320848675076,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,69,1.04 [1.01-1.07],0.00318882291583834,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,Inverse variance weighted,69,1.05 [1.02-1.09],0.00322936248211089,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SERPINA9,Serpin A9,Inverse variance weighted,69,1.03 [1.01-1.06],0.00328982297334889,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,69,1.05 [1.02-1.09],0.00332370109649693,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KHK,Ketohexokinase,Inverse variance weighted,69,1.05 [1.02-1.08],0.00334974048910059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DSG2,Desmoglein-2,Inverse variance weighted,69,0.94 [0.91-0.98],0.00335499823408969,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CRISP3,Cysteine-rich secretory protein 3,Inverse variance weighted,69,0.95 [0.92-0.98],0.00340521926967091,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CA14,Carbonic anhydrase 14,Inverse variance weighted,69,0.96 [0.93-0.99],0.00354155253922604,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,69,1.03 [1.01-1.06],0.00370071965095227,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLXDC2,Plexin domain-containing protein 2,Inverse variance weighted,69,1.04 [1.01-1.07],0.00374179893442202,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HAO1,Hydroxyacid oxidase 1,Inverse variance weighted,69,1.05 [1.02-1.08],0.00374456094595839,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CTSZ,Cathepsin Z,Inverse variance weighted,69,1.04 [1.01-1.06],0.00374906026967571,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CTSS,Cathepsin S,Inverse variance weighted,69,1.04 [1.01-1.07],0.00378110134233413,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNXB,Tenascin-X,Inverse variance weighted,69,0.96 [0.94-0.99],0.00382612175776722,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,69,0.93 [0.88-0.98],0.00405350474713069,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,C9,Complement component C9,Inverse variance weighted,69,0.95 [0.91-0.98],0.00406641095576832,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GOLM2,Protein GOLM2,Inverse variance weighted,69,1.04 [1.01-1.07],0.00419506622861351,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,Inverse variance weighted,69,1.04 [1.01-1.06],0.00420887999714894,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CEMIP2,Cell surface hyaluronidase,Inverse variance weighted,69,1.04 [1.01-1.07],0.00436986785114775,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HJV,Hemojuvelin,Inverse variance weighted,69,1.04 [1.01-1.07],0.00453244007145674,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADA2,Adenosine deaminase 2,Inverse variance weighted,69,1.05 [1.01-1.08],0.00460294760782159,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GLB1,Beta-galactosidase,Inverse variance weighted,69,1.04 [1.01-1.07],0.00475832210429889,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,69,1.04 [1.01-1.07],0.00493646144461866,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,69,1.04 [1.01-1.06],0.00501181824716483,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CNTN2,Contactin-2,Inverse variance weighted,69,1.04 [1.01-1.06],0.00502176248795137,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GHRL,Appetite-regulating hormone,Inverse variance weighted,69,0.96 [0.93-0.99],0.00506503968783542,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TEK,Angiopoietin-1 receptor,Inverse variance weighted,69,1.03 [1.01-1.06],0.00515912745905499,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,Inverse variance weighted,69,1.04 [1.01-1.06],0.00524381873365181,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CNTN3,Contactin-3,Inverse variance weighted,69,1.07 [1.02-1.12],0.0052941886680665,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,Inverse variance weighted,69,1.03 [1.01-1.06],0.00537113810679363,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TMPRSS15,Enteropeptidase,Inverse variance weighted,69,1.05 [1.01-1.09],0.00569870166455019,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MEP1A,Meprin A subunit alpha,Inverse variance weighted,69,1.06 [1.02-1.11],0.00595114660437692,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,69,0.95 [0.92-0.99],0.00616862145754712,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,69,1.04 [1.01-1.07],0.00650235297621366,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MVK,Mevalonate kinase,Inverse variance weighted,69,1.04 [1.01-1.07],0.00652775601844951,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DHPS,Deoxyhypusine synthase,Inverse variance weighted,69,1.04 [1.01-1.07],0.00680214914814136,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFSF12,Tumor necrosis factor ligand superfamily member 12,Inverse variance weighted,69,0.97 [0.94-0.99],0.00687824677333588,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTPRF,Receptor-type tyrosine-protein phosphatase F,Inverse variance weighted,69,0.95 [0.92-0.99],0.00702559526548271,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MTUS1,Microtubule-associated tumor suppressor 1,Inverse variance weighted,69,1.03 [1.01-1.06],0.00714583439857885,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,69,1.04 [1.01-1.07],0.00731848752361284,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GLA,Alpha-galactosidase A,Inverse variance weighted,69,1.05 [1.01-1.09],0.00782001250450159,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PODXL2,Podocalyxin-like protein 2,Inverse variance weighted,69,0.96 [0.93-0.99],0.00817897344969585,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,69,1.04 [1.01-1.07],0.00826218588562009,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IGSF9,Protein turtle homolog A,Inverse variance weighted,69,1.09 [1.02-1.16],0.00854486000899823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,C19orf12,Protein C19orf12,Inverse variance weighted,69,1.04 [1.01-1.08],0.00858170605369181,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD300LG,CMRF35-like molecule 9,Inverse variance weighted,69,0.95 [0.91-0.99],0.00900681168154078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ERBB2,Receptor tyrosine-protein kinase erbB-2,Inverse variance weighted,69,1.04 [1.01-1.07],0.00964897351357038,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FCRL5,Fc receptor-like protein 5,Inverse variance weighted,69,1.04 [1.01-1.07],0.00976634231995408,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,69,1.03 [1.01-1.06],0.00977994969818419,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,69,1.03 [1.01-1.06],0.00981735855208909,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LDLR,Low-density lipoprotein receptor,Inverse variance weighted,69,1.06 [1.01-1.11],0.00999275000617174,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IFNLR1,Interferon lambda receptor 1,Inverse variance weighted,69,1.04 [1.01-1.06],0.01003402222831,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SELL,L-selectin,Inverse variance weighted,69,0.96 [0.93-0.99],0.0102639469085164,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CYTL1,Cytokine-like protein 1,Inverse variance weighted,69,0.97 [0.94-0.99],0.010286209631017,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GCG,Pro-glucagon,Inverse variance weighted,69,1.05 [1.01-1.09],0.0104308212432523,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,69,1.04 [1.01-1.07],0.0105873276137579,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NME3,Nucleoside diphosphate kinase 3,Inverse variance weighted,69,0.96 [0.93-0.99],0.0106600857895265,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,Inverse variance weighted,69,0.96 [0.93-0.99],0.0107706924769661,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,69,1.03 [1.01-1.06],0.0110597512348567,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NPL,N-acetylneuraminate lyase,Inverse variance weighted,69,1.04 [1.01-1.07],0.011080870906387,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,69,0.96 [0.94-0.99],0.0116219818713172,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,69,1.04 [1.01-1.08],0.0116395871520382,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AKR7L,Aflatoxin B1 aldehyde reductase member 4,Inverse variance weighted,69,1.04 [1.01-1.07],0.0117064747254685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDH2,Cadherin-2,Inverse variance weighted,69,1.04 [1.01-1.07],0.0118144387173374,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,69,1.03 [1.01-1.06],0.0120373581900997,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CTSD,Cathepsin D,Inverse variance weighted,69,1.05 [1.01-1.09],0.0120896043963325,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,69,1.04 [1.01-1.08],0.0123137962080553,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,APOM,Apolipoprotein M,Inverse variance weighted,69,0.95 [0.91-0.99],0.0124112751710732,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EFNA4,Ephrin-A4,Inverse variance weighted,69,1.03 [1.01-1.06],0.0125647759741968,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CRH,Corticoliberin,Inverse variance weighted,69,0.96 [0.93-0.99],0.0129715756894523,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GPKOW,G-patch domain and KOW motifs-containing protein,Inverse variance weighted,69,1.03 [1.01-1.06],0.0129915391534425,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NADK,NAD kinase,Inverse variance weighted,69,1.04 [1.01-1.07],0.0132054447728506,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,69,1.04 [1.01-1.07],0.0138036013886758,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SCG2,Secretogranin-2,Inverse variance weighted,69,1.03 [1.01-1.06],0.013836798979404,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LAMP1,Lysosome-associated membrane glycoprotein 1,Inverse variance weighted,69,1.03 [1.01-1.06],0.0138804842501869,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ITGB7,Integrin beta-7,Inverse variance weighted,69,1.03 [1.01-1.06],0.0138914437793871,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MMP7,Matrilysin,Inverse variance weighted,69,1.03 [1.01-1.05],0.0139919651780579,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MMP12,Macrophage metalloelastase,Inverse variance weighted,69,1.03 [1.01-1.06],0.0140641556189818,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PEPD,Xaa-Pro dipeptidase,Inverse variance weighted,69,0.97 [0.94-0.99],0.014101546629807,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ENTR1,Endosome-associated-trafficking regulator 1,Inverse variance weighted,69,1.04 [1.01-1.07],0.0141554762815029,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,69,1.03 [1.01-1.06],0.0142662580191292,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,69,0.95 [0.92-0.99],0.0143542932421991,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,69,1.03 [1.01-1.06],0.014367993027838,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CHRDL2,Chordin-like protein 2,Inverse variance weighted,69,1.03 [1.01-1.06],0.0143711679911122,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CES3,Carboxylesterase 3,Inverse variance weighted,69,1.05 [1.01-1.08],0.0144057628759693,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DIPK2B,Divergent protein kinase domain 2B,Inverse variance weighted,69,0.96 [0.94-0.99],0.0146027492311358,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,69,1.04 [1.01-1.06],0.014902382253223,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,69,0.96 [0.92-0.99],0.0149596211092133,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CPVL,Probable serine carboxypeptidase CPVL,Inverse variance weighted,69,1.03 [1.01-1.05],0.0150710299759297,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SORD,Sorbitol dehydrogenase,Inverse variance weighted,69,1.05 [1.01-1.08],0.0150855480658484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SUOX,"Sulfite oxidase, mitochondrial",Inverse variance weighted,69,1.04 [1.01-1.07],0.0150924247146476,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SPARCL1,SPARC-like protein 1,Inverse variance weighted,69,0.97 [0.95-0.99],0.0151802230856231,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,Inverse variance weighted,69,0.96 [0.93-0.99],0.0158876286493738,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL20,C-C motif chemokine 20,Inverse variance weighted,69,1.04 [1.01-1.07],0.0159275148695882,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ATRN,"Attractin, Isoform 2",Inverse variance weighted,69,1.04 [1.01-1.08],0.0159938272143123,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,69,1.03 [1.01-1.05],0.0161379686703857,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GSR,"Glutathione reductase, mitochondrial",Inverse variance weighted,69,0.97 [0.94-0.99],0.0163295599840047,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LAMB1,Laminin subunit beta-1,Inverse variance weighted,69,1.03 [1.01-1.06],0.0163666693882552,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CTSE,Cathepsin E,Inverse variance weighted,69,1.04 [1.01-1.08],0.0164231923008883,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCN1,CCN family member 1,Inverse variance weighted,69,1.04 [1.01-1.08],0.0164644005037578,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ACE,Angiotensin-converting enzyme,Inverse variance weighted,69,1.03 [1.01-1.06],0.0168330826180589,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ITGAL,Integrin alpha-L,Inverse variance weighted,69,1.03 [1.01-1.06],0.0169045550788021,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KLK11,Kallikrein-11,Inverse variance weighted,69,0.97 [0.94-0.99],0.0169536645939762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,69,1.03 [1.01-1.05],0.0173906054593315,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,69,1.04 [1.01-1.07],0.0173957333425771,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ENO3,Beta-enolase,Inverse variance weighted,69,1.04 [1.01-1.08],0.0175258427269711,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ART3,Ecto-ADP-ribosyltransferase 3,Inverse variance weighted,69,0.96 [0.93-0.99],0.0175987176156493,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,Inverse variance weighted,69,1.03 [1.01-1.06],0.0178810737993467,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,69,0.95 [0.91-0.99],0.0180540821204199,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SIGLEC1,Sialoadhesin,Inverse variance weighted,69,1.03 [1.01-1.06],0.0184556304394964,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTP4A3,Protein tyrosine phosphatase type IVA 3,Inverse variance weighted,69,1.04 [1.01-1.07],0.0184784109232633,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ITGAM,Integrin alpha-M,Inverse variance weighted,69,1.04 [1.01-1.07],0.0185972422363147,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,69,0.96 [0.93-0.99],0.0189612466180973,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PSAPL1,Proactivator polypeptide-like 1,Inverse variance weighted,69,0.97 [0.94-0.99],0.0189755772580439,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDH15,Cadherin-15,Inverse variance weighted,69,1.03 [1.01-1.06],0.0190957836950195,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,69,1.03 [1.01-1.06],0.0191537426308192,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,APOA1,Apolipoprotein A-I,Inverse variance weighted,69,0.97 [0.94-0.99],0.0198707054570386,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",Inverse variance weighted,69,0.96 [0.93-0.99],0.0201591094477762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,OPTC,Opticin,Inverse variance weighted,69,0.96 [0.94-0.99],0.0202775710947602,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HIP1R,Huntingtin-interacting protein 1-related protein,Inverse variance weighted,69,1.03 [1-1.05],0.0202809222052963,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ELOA,Elongin-A,Inverse variance weighted,69,1.03 [1.01-1.06],0.0206508989797651,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,69,1.04 [1.01-1.07],0.0210341640611971,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,69,1.03 [1-1.06],0.0210369075170172,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,69,1.04 [1.01-1.07],0.0211293555823872,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,69,1.04 [1.01-1.07],0.0218103010663357,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,UMOD,Uromodulin,Inverse variance weighted,69,0.97 [0.94-0.99],0.0218901042350084,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EGLN1,Egl nine homolog 1,Inverse variance weighted,69,1.03 [1-1.06],0.022478337294133,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,69,1.03 [1-1.06],0.0229874087840134,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DDT,D-dopachrome decarboxylase,Inverse variance weighted,69,1.03 [1-1.06],0.0234713112715685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MEPE,Matrix extracellular phosphoglycoprotein,Inverse variance weighted,69,0.96 [0.93-0.99],0.0237748161790145,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,69,0.97 [0.94-1],0.0238143643917993,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PRUNE2,Protein prune homolog 2,Inverse variance weighted,69,1.03 [1-1.05],0.0242151475867376,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL16,Pro-interleukin-16,Inverse variance weighted,69,1.03 [1-1.06],0.0249316637714539,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,69,1.05 [1.01-1.09],0.0250562480046765,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CHL1,Neural cell adhesion molecule L1-like protein,Inverse variance weighted,69,0.97 [0.94-1],0.0257326875640535,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AGRP,Agouti-related protein,Inverse variance weighted,69,1.04 [1.01-1.09],0.025799475086886,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,69,1.03 [1-1.06],0.0258718734644024,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PAMR1,Inactive serine protease PAMR1,Inverse variance weighted,69,1.04 [1-1.08],0.0259094723032329,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLB1,"Phospholipase B1, membrane-associated",Inverse variance weighted,69,0.98 [0.96-1],0.0259873781572318,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FURIN,Furin,Inverse variance weighted,69,1.06 [1.01-1.11],0.0267219415671325,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CPQ,Carboxypeptidase Q,Inverse variance weighted,69,1.03 [1-1.06],0.0267776283158841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TFF1,Trefoil factor 1,Inverse variance weighted,69,1.03 [1-1.05],0.0269725923626549,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL7R,Interleukin-7 receptor subunit alpha,Inverse variance weighted,69,0.97 [0.95-1],0.0272198550685218,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PRSS8,Prostasin,Inverse variance weighted,69,1.05 [1-1.09],0.0277831994256642,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,69,0.97 [0.94-1],0.0279734146542227,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SLITRK2,SLIT and NTRK-like protein 2,Inverse variance weighted,69,1.03 [1-1.06],0.0281398754691214,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,C7,Complement component C7,Inverse variance weighted,69,1.03 [1-1.06],0.028393168038503,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DYNLT1,Dynein light chain Tctex-type 1,Inverse variance weighted,69,1.02 [1-1.04],0.0288728393519925,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CBS,Cystathionine beta-synthase,Inverse variance weighted,69,1.03 [1-1.06],0.0290060574091044,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,S100P,Protein S100-P,Inverse variance weighted,69,1.03 [1-1.06],0.0292767474225189,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,69,0.97 [0.94-1],0.0293539132978605,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SFRP4,Secreted frizzled-related protein 4,Inverse variance weighted,69,1.03 [1-1.06],0.0294670195119805,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VWC2L,von Willebrand factor C domain-containing protein 2-like,Inverse variance weighted,69,0.97 [0.95-1],0.0296231050183913,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CXCL6,C-X-C motif chemokine 6,Inverse variance weighted,69,1.03 [1-1.07],0.0297568413201095,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,69,1.03 [1-1.06],0.0297627028394502,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RBKS,Ribokinase,Inverse variance weighted,69,1.04 [1-1.07],0.0298733906411481,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KIAA0319,Dyslexia-associated protein KIAA0319,Inverse variance weighted,69,0.97 [0.94-1],0.0307473640454752,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PRG2,Bone marrow proteoglycan,Inverse variance weighted,69,0.96 [0.93-1],0.0309836273466008,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,69,1.03 [1-1.06],0.0318105373150323,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PARP1,Poly [ADP-ribose] polymerase 1,Inverse variance weighted,69,1.03 [1-1.06],0.0326481914552678,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FGF19,Fibroblast growth factor 19,Inverse variance weighted,69,0.97 [0.94-1],0.0329707763721284,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL13RA1,Interleukin-13 receptor subunit alpha-1,Inverse variance weighted,69,1.03 [1-1.07],0.033319197436719,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,69,1.03 [1-1.06],0.0333246716726821,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,69,1.03 [1-1.06],0.0333549820744693,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTPRM,Receptor-type tyrosine-protein phosphatase mu,Inverse variance weighted,69,1.03 [1-1.05],0.0334976273598111,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CTRC,Chymotrypsin-C,Inverse variance weighted,69,0.97 [0.94-1],0.0335319029123923,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,Inverse variance weighted,69,1.03 [1-1.06],0.033567182607297,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NCF2,Neutrophil cytosol factor 2,Inverse variance weighted,69,1.03 [1-1.05],0.0335918436264535,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL17C,Interleukin-17C,Inverse variance weighted,69,1.03 [1-1.05],0.0337584247788873,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,69,1.03 [1-1.06],0.033973410881746,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SERPINI1,Neuroserpin,Inverse variance weighted,69,0.97 [0.95-1],0.0350694802108264,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,69,1.03 [1-1.07],0.0351958312202295,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,69,1.03 [1-1.06],0.0352362767627323,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SRP14,Signal recognition particle 14 kDa protein,Inverse variance weighted,69,1.03 [1-1.06],0.0352932267400982,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FMNL1,Formin-like protein 1,Inverse variance weighted,69,1.03 [1-1.05],0.0356275510637118,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ARSA,Arylsulfatase A,Inverse variance weighted,69,1.03 [1-1.06],0.0363653023525052,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CLEC4M,C-type lectin domain family 4 member M,Inverse variance weighted,69,0.98 [0.95-1],0.0366886749387436,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HMCN2,Hemicentin-2,Inverse variance weighted,69,1.02 [1-1.05],0.0367217961420799,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Inverse variance weighted,69,1.03 [1-1.05],0.0368622271632974,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,69,1.04 [1-1.08],0.0377529238862816,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,69,1.03 [1-1.07],0.0377707293382101,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,69,1.03 [1-1.06],0.0386170248247153,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD22,B-cell receptor CD22,Inverse variance weighted,69,1.03 [1-1.06],0.0389229946449722,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDHR5,Cadherin-related family member 5,Inverse variance weighted,69,1.03 [1-1.07],0.0390853685183012,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CBLN4,Cerebellin-4,Inverse variance weighted,69,1.04 [1-1.08],0.0401614132523719,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NTRK2,BDNF/NT-3 growth factors receptor,Inverse variance weighted,69,1.04 [1-1.07],0.0402677014269572,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NPPC,C-type natriuretic peptide,Inverse variance weighted,69,1.03 [1-1.05],0.0404846812278574,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,69,1.03 [1-1.05],0.0405603285006858,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GPD1,Glycerol-3-phosphate dehydrogenase,Inverse variance weighted,69,1.04 [1-1.07],0.0416715113210101,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CXCL12,Stromal cell-derived factor 1,Inverse variance weighted,69,0.97 [0.95-1],0.0419977027888933,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTGR1,Prostaglandin reductase 1,Inverse variance weighted,69,1.03 [1-1.07],0.0425092925680796,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BPIFB2,BPI fold-containing family B member 2,Inverse variance weighted,69,1.04 [1-1.08],0.0425840955502048,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KLRF1,Killer cell lectin-like receptor subfamily F member 1,Inverse variance weighted,69,1.03 [1-1.06],0.0426720690499347,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL18,Interleukin-18,Inverse variance weighted,69,1.03 [1-1.05],0.0435161048381046,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PCDH9,Protocadherin-9,Inverse variance weighted,69,1.03 [1-1.05],0.0438758925420737,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ASS1,Argininosuccinate synthase,Inverse variance weighted,69,1.03 [1-1.07],0.0442152154510418,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,69,1.04 [1-1.07],0.0449282784202978,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,OCLN,Occludin,Inverse variance weighted,69,1.03 [1-1.06],0.0456417097115917,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD2AP,CD2-associated protein,Inverse variance weighted,69,1.03 [1-1.06],0.0466181419150802,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BCAN,Brevican core protein,Inverse variance weighted,69,0.97 [0.94-1],0.047093382729703,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,OXT,Oxytocin-neurophysin 1,Inverse variance weighted,69,1.04 [1-1.08],0.0474668204947909,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,69,0.97 [0.94-1],0.0474954906204138,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,69,1.03 [1-1.07],0.0486823200667467,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BCL2L15,Bcl-2-like protein 15,Inverse variance weighted,69,1.02 [1-1.05],0.0486939301170596,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",Inverse variance weighted,69,1.02 [1-1.05],0.0498402288735518,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LGMN,Legumain,Inverse variance weighted,69,1.03 [1-1.06],0.0504913865851765,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL5RA,Interleukin-5 receptor subunit alpha,Inverse variance weighted,69,1.03 [1-1.06],0.0512122447914404,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,69,1.03 [1-1.06],0.0518614020397616,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MFGE8,Lactadherin,Inverse variance weighted,69,1.04 [1-1.08],0.0519788696544268,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SCPEP1,Retinoid-inducible serine carboxypeptidase,Inverse variance weighted,69,1.03 [1-1.07],0.052293484611123,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",Inverse variance weighted,69,1.03 [1-1.06],0.0524291999951465,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DKK4,Dickkopf-related protein 4,Inverse variance weighted,69,1.03 [1-1.05],0.0526587019308057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EGFR,Epidermal growth factor receptor,Inverse variance weighted,69,0.97 [0.93-1],0.0531121454524282,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,69,1.03 [1-1.06],0.0537033122385551,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FGFBP3,Fibroblast growth factor-binding protein 3,Inverse variance weighted,69,0.96 [0.92-1],0.0539549613535644,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,69,1.02 [1-1.05],0.0553851139935631,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,69,0.97 [0.94-1],0.0563116686383787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,69,1.03 [1-1.06],0.0566215340839115,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CFC1,Cryptic protein,Inverse variance weighted,69,0.96 [0.92-1],0.0566550282593823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,COMP,Cartilage oligomeric matrix protein,Inverse variance weighted,69,0.97 [0.94-1],0.0566883271292189,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,69,1.03 [1-1.06],0.0578910028964465,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,WNT9A,Protein Wnt-9a,Inverse variance weighted,69,0.97 [0.95-1],0.0580816204561355,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SCLY,Selenocysteine lyase,Inverse variance weighted,69,1.03 [1-1.06],0.0584981594604088,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BTD,Biotinidase,Inverse variance weighted,69,1.03 [1-1.07],0.0593817451116386,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KCTD5,BTB/POZ domain-containing protein KCTD5,Inverse variance weighted,69,1.03 [1-1.05],0.059653457527143,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GZMA,Granzyme A,Inverse variance weighted,69,1.03 [1-1.06],0.0597167835941582,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NOMO1,Nodal modulator 1,Inverse variance weighted,69,1.03 [1-1.06],0.0599171969949302,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,69,1.03 [1-1.07],0.0602654622755244,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL7,C-C motif chemokine 7,Inverse variance weighted,69,1.03 [1-1.06],0.0613008777519153,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SNRPB2,U2 small nuclear ribonucleoprotein B'',Inverse variance weighted,69,1.02 [1-1.05],0.0613248830743354,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SBSN,Suprabasin,Inverse variance weighted,69,0.97 [0.93-1],0.0614487201712036,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SUSD5,Sushi domain-containing protein 5,Inverse variance weighted,69,0.97 [0.94-1],0.0630274101855623,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DLK1,Protein delta homolog 1,Inverse variance weighted,69,1.03 [1-1.06],0.0632582453552413,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CRTAC1,Cartilage acidic protein 1,Inverse variance weighted,69,0.98 [0.96-1],0.0633106822598728,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,APLP1,Amyloid-like protein 1,Inverse variance weighted,69,0.97 [0.95-1],0.0650881896895276,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ITGA5,Integrin alpha-5,Inverse variance weighted,69,1.02 [1-1.05],0.0658022751783756,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FCN1,Ficolin-1,Inverse variance weighted,69,0.97 [0.94-1],0.0662326639019937,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SOST,Sclerostin,Inverse variance weighted,69,1.03 [1-1.06],0.0665498861112119,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,69,1.03 [1-1.07],0.0666931035587782,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CST7,Cystatin-F,Inverse variance weighted,69,1.02 [1-1.04],0.0668904895325622,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SERPINA4,Kallistatin,Inverse variance weighted,69,1.04 [1-1.08],0.0669266665309787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CES1,Liver carboxylesterase 1,Inverse variance weighted,69,1.05 [1-1.1],0.0670065177845935,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,C2,Complement C2,Inverse variance weighted,69,1.03 [1-1.07],0.0670274921039764,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL3,C-C motif chemokine 3,Inverse variance weighted,69,1.03 [1-1.06],0.0678789289624112,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,Inverse variance weighted,69,1.02 [1-1.04],0.069103911345435,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,69,1.03 [1-1.06],0.070585930591678,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,69,0.97 [0.95-1],0.0709486775192232,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,Inverse variance weighted,69,0.98 [0.95-1],0.0722431490711223,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AMBP,Protein AMBP,Inverse variance weighted,69,1.03 [1-1.06],0.0722710072907021,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,69,0.97 [0.94-1],0.0728339851766196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TP53I3,Quinone oxidoreductase PIG3,Inverse variance weighted,69,1.02 [1-1.05],0.0729768583065079,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LAMP2,Lysosome-associated membrane glycoprotein 2,Inverse variance weighted,69,1.03 [1-1.07],0.0745543535535097,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,Inverse variance weighted,69,1.02 [1-1.04],0.0753704957219815,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AMY2A,Pancreatic alpha-amylase,Inverse variance weighted,69,0.98 [0.95-1],0.0758564128729318,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GALNT7,N-acetylgalactosaminyltransferase 7,Inverse variance weighted,69,1.02 [1-1.05],0.0762040582985172,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FBLN2,Fibulin-2,Inverse variance weighted,69,0.97 [0.93-1],0.0772192955816466,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,Inverse variance weighted,69,1.02 [1-1.05],0.077473530170073,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLTP,Phospholipid transfer protein,Inverse variance weighted,69,0.97 [0.94-1],0.0783236409717211,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,69,0.97 [0.94-1],0.0790288722052969,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CLEC3B,Tetranectin,Inverse variance weighted,69,0.98 [0.95-1],0.0794540436814023,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,THOP1,Thimet oligopeptidase,Inverse variance weighted,69,1.02 [1-1.05],0.0798092288716966,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,69,0.97 [0.94-1],0.0803764505005065,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL19,C-C motif chemokine 19,Inverse variance weighted,69,1.03 [1-1.06],0.0816643130332165,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD34,Hematopoietic progenitor cell antigen CD34,Inverse variance weighted,69,0.97 [0.94-1],0.0829507208365629,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SKAP1,Src kinase-associated phosphoprotein 1,Inverse variance weighted,69,1.02 [1-1.05],0.0831905016924465,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,69,1.02 [1-1.05],0.085554093515816,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LCP1,Plastin-2,Inverse variance weighted,69,0.98 [0.95-1],0.0856100624495277,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,69,1.03 [1-1.06],0.0866141114475518,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TCOF1,Treacle protein,Inverse variance weighted,69,1.02 [1-1.05],0.0880940312747378,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PVR,Poliovirus receptor,Inverse variance weighted,69,1.02 [1-1.05],0.0886435106582122,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DSG4,Desmoglein-4,Inverse variance weighted,69,0.97 [0.94-1],0.088787749528108,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,69,0.98 [0.95-1],0.0891509991136732,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,69,0.97 [0.95-1],0.0894849781239998,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,69,0.97 [0.95-1],0.0898260285181855,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,69,1.02 [1-1.05],0.0899577976984442,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,69,0.98 [0.96-1],0.0900182587267836,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,STC1,Stanniocalcin-1,Inverse variance weighted,69,1.02 [1-1.05],0.0907819517313011,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,Inverse variance weighted,69,1.02 [1-1.05],0.0922246459899348,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LCAT,Phosphatidylcholine-sterol acyltransferase,Inverse variance weighted,69,1.04 [0.99-1.08],0.0923385995177116,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,69,0.98 [0.95-1],0.0925113118103467,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AMY2B,Alpha-amylase 2B,Inverse variance weighted,69,0.98 [0.95-1],0.0935166087183926,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,69,0.96 [0.92-1.01],0.0939395381894525,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,Inverse variance weighted,69,1.02 [1-1.05],0.0941823071629146,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,69,1.02 [1-1.04],0.0949833103783567,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,69,1.02 [1-1.05],0.0977197333174744,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SHMT1,"Serine hydroxymethyltransferase, cytosolic",Inverse variance weighted,69,1.04 [0.99-1.08],0.0983884171983374,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL4,C-C motif chemokine 4,Inverse variance weighted,69,1.03 [0.99-1.07],0.0998812744959236,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,69,1.02 [1-1.04],0.100615476489906,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTPRC,Receptor-type tyrosine-protein phosphatase C,Inverse variance weighted,69,1.02 [1-1.04],0.10296297606501,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,69,0.98 [0.95-1],0.10341760423093,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,69,1.04 [0.99-1.08],0.103442795961249,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,69,1.03 [0.99-1.06],0.104587439054348,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTN,Pleiotrophin,Inverse variance weighted,69,0.98 [0.95-1],0.104652769430336,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ITGB6,Integrin beta-6,Inverse variance weighted,69,1.02 [1-1.05],0.105127157407208,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLA2G1B,Phospholipase A2,Inverse variance weighted,69,0.97 [0.94-1.01],0.105333748600762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD99,CD99 antigen,Inverse variance weighted,69,0.97 [0.94-1.01],0.105380433076419,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL16,C-C motif chemokine 16,Inverse variance weighted,69,1.02 [0.99-1.05],0.105527622741811,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNN,Tenascin-N,Inverse variance weighted,69,1.02 [1-1.04],0.106285965708516,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,69,1.02 [1-1.05],0.10817938671741,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SMAD1,Mothers against decapentaplegic homolog 1,Inverse variance weighted,69,1.03 [0.99-1.06],0.108394260331395,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,69,0.97 [0.93-1.01],0.108716650362122,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SLAMF8,SLAM family member 8,Inverse variance weighted,69,1.02 [1-1.05],0.109577626939717,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LSP1,Lymphocyte-specific protein 1,Inverse variance weighted,69,1.02 [1-1.05],0.109795413213393,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL22,C-C motif chemokine 22,Inverse variance weighted,69,1.03 [0.99-1.06],0.109924458177221,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,69,1.02 [1-1.05],0.111076137464188,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AGRN,Agrin,Inverse variance weighted,69,1.03 [0.99-1.06],0.112080360761895,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,69,1.02 [1-1.05],0.112537158283867,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CHRDL1,Chordin-like protein 1,Inverse variance weighted,69,0.98 [0.95-1.01],0.113066759364312,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,69,1.02 [0.99-1.05],0.113144521614788,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLIN1,Perilipin-1,Inverse variance weighted,69,1.03 [0.99-1.06],0.113649634935399,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD248,Endosialin,Inverse variance weighted,69,0.97 [0.94-1.01],0.114492532008686,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,69,1.02 [0.99-1.05],0.114918591318847,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,C3,Complement C3,Inverse variance weighted,69,1.03 [0.99-1.07],0.115404717625096,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SEMA7A,Semaphorin-7A,Inverse variance weighted,69,1.03 [0.99-1.06],0.115663936310239,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,69,1.03 [0.99-1.06],0.116509202742865,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTPRH,Receptor-type tyrosine-protein phosphatase H,Inverse variance weighted,69,1.02 [0.99-1.05],0.116863111761807,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ZNRD2,Protein ZNRD2,Inverse variance weighted,69,1.03 [0.99-1.06],0.117882910516706,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NT5E,5'-nucleotidase,Inverse variance weighted,69,1.02 [0.99-1.05],0.118201952244736,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,69,0.99 [0.97-1],0.12151525119893,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,69,1.02 [0.99-1.04],0.122864883786952,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BMP4,Bone morphogenetic protein 4,Inverse variance weighted,69,1.02 [0.99-1.05],0.123174405512252,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCN4,CCN family member 4,Inverse variance weighted,69,1.02 [1-1.04],0.123413198416413,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,69,1.04 [0.99-1.08],0.125622163497248,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SLAMF7,SLAM family member 7,Inverse variance weighted,69,1.02 [0.99-1.05],0.1259003037454,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MEGF9,Multiple epidermal growth factor-like domains protein 9,Inverse variance weighted,69,1.02 [0.99-1.06],0.127675939729685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ANG,Angiogenin,Inverse variance weighted,69,1.02 [0.99-1.05],0.128358802608057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CRLF1,Cytokine receptor-like factor 1,Inverse variance weighted,69,1.03 [0.99-1.06],0.12938295562685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MCAM,Cell surface glycoprotein MUC18,Inverse variance weighted,69,0.97 [0.93-1.01],0.131930776151055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,Inverse variance weighted,69,1.02 [0.99-1.04],0.13232805202421,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",Inverse variance weighted,69,0.98 [0.95-1.01],0.13253760586206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LEO1,RNA polymerase-associated protein LEO1,Inverse variance weighted,69,1.02 [0.99-1.05],0.134063716165613,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,STAB2,Stabilin-2,Inverse variance weighted,69,1.02 [0.99-1.04],0.137680799664615,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PXN,Paxillin,Inverse variance weighted,69,1.02 [0.99-1.04],0.138068311627391,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KYNU,Kynureninase,Inverse variance weighted,69,1.02 [0.99-1.06],0.138149144087606,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CPE,Carboxypeptidase E,Inverse variance weighted,69,0.98 [0.95-1.01],0.138431341219728,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,69,1.02 [0.99-1.05],0.141696001216058,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LAP3,Cytosol aminopeptidase,Inverse variance weighted,69,1.02 [0.99-1.05],0.141755136163025,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,69,0.98 [0.96-1.01],0.142183318551888,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SMNDC1,Survival of motor neuron-related-splicing factor 30,Inverse variance weighted,69,1.02 [0.99-1.05],0.142271374434671,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LAYN,Layilin,Inverse variance weighted,69,0.98 [0.95-1.01],0.142487306529086,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FGF21,Fibroblast growth factor 21,Inverse variance weighted,69,1.05 [0.99-1.11],0.142966943634563,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,APOE,Apolipoprotein E,Inverse variance weighted,69,0.98 [0.95-1.01],0.143265932159731,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,69,0.98 [0.95-1.01],0.143274690353943,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NECTIN4,Nectin-4,Inverse variance weighted,69,0.97 [0.94-1.01],0.144001374544666,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CXCL13,C-X-C motif chemokine 13,Inverse variance weighted,69,1.03 [0.99-1.06],0.144294092084237,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RSPO3,R-spondin-3,Inverse variance weighted,69,0.98 [0.95-1.01],0.144335246155747,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GLO1,Lactoylglutathione lyase,Inverse variance weighted,69,1.02 [0.99-1.05],0.14632692175229,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",Inverse variance weighted,69,1.02 [0.99-1.05],0.146580921539954,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TCN2,Transcobalamin-2,Inverse variance weighted,69,1.02 [0.99-1.04],0.146933276649487,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VEGFD,Vascular endothelial growth factor D,Inverse variance weighted,69,1.03 [0.99-1.06],0.147196942937139,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ITGA11,Integrin alpha-11,Inverse variance weighted,69,0.98 [0.95-1.01],0.148385779851106,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,69,0.98 [0.95-1.01],0.148655082082144,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,69,0.98 [0.95-1.01],0.15006369340055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DNPEP,Aspartyl aminopeptidase,Inverse variance weighted,69,1.02 [0.99-1.04],0.1512351401487,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DMD,Dystrophin,Inverse variance weighted,69,1.02 [0.99-1.04],0.152230334337667,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,69,0.97 [0.94-1.01],0.152747352135526,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,69,1.02 [0.99-1.06],0.15557245094018,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,OSM,Oncostatin-M,Inverse variance weighted,69,1.02 [0.99-1.05],0.155653534335908,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VSNL1,Visinin-like protein 1,Inverse variance weighted,69,1.02 [0.99-1.04],0.155995072436456,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,69,0.98 [0.95-1.01],0.157018780917663,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MLN,Promotilin,Inverse variance weighted,69,1.04 [0.98-1.1],0.157213930346172,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,69,1.02 [0.99-1.05],0.157552289342183,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,69,0.98 [0.95-1.01],0.158049728831975,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GUCA2A,Guanylin,Inverse variance weighted,69,0.98 [0.95-1.01],0.158949367346517,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MAMDC4,Apical endosomal glycoprotein,Inverse variance weighted,69,1.04 [0.98-1.1],0.160642555160972,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HNMT,Histamine N-methyltransferase,Inverse variance weighted,69,1.02 [0.99-1.04],0.161126327608726,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LGALS9,Galectin-9,Inverse variance weighted,69,1.02 [0.99-1.05],0.163500169182049,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD244,Natural killer cell receptor 2B4,Inverse variance weighted,69,1.02 [0.99-1.05],0.163580649027316,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BAP18,Chromatin complexes subunit BAP18,Inverse variance weighted,69,1.02 [0.99-1.05],0.163678185947643,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GGH,Gamma-glutamyl hydrolase,Inverse variance weighted,69,1.02 [0.99-1.06],0.164311918745132,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,REG1A,Lithostathine-1-alpha,Inverse variance weighted,69,1.02 [0.99-1.04],0.165944043247428,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LY96,Lymphocyte antigen 96,Inverse variance weighted,69,1.02 [0.99-1.05],0.166168003245689,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,69,1.02 [0.99-1.05],0.166281846534881,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ANXA5,Annexin A5,Inverse variance weighted,69,1.02 [0.99-1.05],0.166528596525495,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDKN1A,Cyclin-dependent kinase inhibitor 1,Inverse variance weighted,69,1.02 [0.99-1.05],0.168237898595412,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DPY30,Protein dpy-30 homolog,Inverse variance weighted,69,1.02 [0.99-1.05],0.168360090160546,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,Inverse variance weighted,69,1.02 [0.99-1.05],0.168860998508806,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TCTN3,Tectonic-3,Inverse variance weighted,69,1.02 [0.99-1.05],0.169864683735066,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,69,0.98 [0.95-1.01],0.171592425774645,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VASN,Vasorin,Inverse variance weighted,69,0.97 [0.94-1.01],0.173345000852144,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDSN,Corneodesmosin,Inverse variance weighted,69,0.98 [0.95-1.01],0.175144467192929,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ICAM4,Intercellular adhesion molecule 4,Inverse variance weighted,69,0.98 [0.95-1.01],0.176199069164196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,69,0.98 [0.94-1.01],0.176296585058999,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,69,0.98 [0.96-1.01],0.176585604730836,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,QDPR,Dihydropteridine reductase,Inverse variance weighted,69,1.02 [0.99-1.05],0.176726292329483,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD63,CD63 antigen,Inverse variance weighted,69,1.02 [0.99-1.05],0.177698631628544,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SPON1,Spondin-1,Inverse variance weighted,69,1.02 [0.99-1.05],0.180455765988593,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SLC16A1,Monocarboxylate transporter 1,Inverse variance weighted,69,1.02 [0.99-1.05],0.180711224254277,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DPP10,Inactive dipeptidyl peptidase 10,Inverse variance weighted,69,1.02 [0.99-1.05],0.1808287682258,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,69,1.01 [0.99-1.03],0.181097765282372,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SLITRK1,SLIT and NTRK-like protein 1,Inverse variance weighted,69,0.98 [0.95-1.01],0.181202381322781,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,INHBB,Inhibin beta B chain,Inverse variance weighted,69,1.02 [0.99-1.05],0.182174040071728,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCS,Copper chaperone for superoxide dismutase,Inverse variance weighted,69,1.02 [0.99-1.04],0.183994142427471,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD48,CD48 antigen,Inverse variance weighted,69,1.02 [0.99-1.04],0.185320026357065,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PCDH1,Protocadherin-1,Inverse variance weighted,69,1.02 [0.99-1.04],0.185386008110614,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TFF2,Trefoil factor 2,Inverse variance weighted,69,1.02 [0.99-1.05],0.18557577637124,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FBP1,"Fructose-1,6-bisphosphatase 1",Inverse variance weighted,69,1.02 [0.99-1.05],0.185723411444908,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AHSG,Alpha-2-HS-glycoprotein,Inverse variance weighted,69,1.02 [0.99-1.04],0.18579457188228,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ALPI,Intestinal-type alkaline phosphatase,Inverse variance weighted,69,1.01 [0.99-1.03],0.186376236436416,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD46,Membrane cofactor protein,Inverse variance weighted,69,0.98 [0.95-1.01],0.187452298744934,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MEP1B,Meprin A subunit beta,Inverse variance weighted,69,1.02 [0.99-1.05],0.18820613781475,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,69,1.02 [0.99-1.04],0.188432246387089,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD276,CD276 antigen,Inverse variance weighted,69,1.02 [0.99-1.05],0.191276189955312,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KLK7,Kallikrein-7,Inverse variance weighted,69,0.98 [0.95-1.01],0.191613551546163,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FST,Follistatin,Inverse variance weighted,69,0.97 [0.93-1.02],0.192841854009851,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,69,0.98 [0.95-1.01],0.193087607401281,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TPR,Nucleoprotein TPR,Inverse variance weighted,69,1.02 [0.99-1.05],0.193153132804216,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RBP2,Retinol-binding protein 2,Inverse variance weighted,69,1.02 [0.99-1.04],0.193399383743174,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LBR,Delta(14)-sterol reductase LBR,Inverse variance weighted,69,1.02 [0.99-1.05],0.193489323756695,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SAT2,Thialysine N-epsilon-acetyltransferase,Inverse variance weighted,69,1.02 [0.99-1.04],0.193527727938756,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ANXA2,Annexin A2,Inverse variance weighted,69,1.02 [0.99-1.05],0.197094943764029,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SERPINA5,Plasma serine protease inhibitor,Inverse variance weighted,69,1.03 [0.99-1.07],0.197630523833777,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NAMPT,Nicotinamide phosphoribosyltransferase,Inverse variance weighted,69,1.02 [0.99-1.04],0.198732398612181,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PALM2,Paralemmin-2,Inverse variance weighted,69,1.02 [0.99-1.05],0.199988771268461,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,APOH,Beta-2-glycoprotein 1,Inverse variance weighted,69,0.99 [0.96-1.01],0.200952980650287,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SNCG,Gamma-synuclein,Inverse variance weighted,69,1.02 [0.99-1.05],0.201757088315966,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BCHE,Cholinesterase,Inverse variance weighted,69,1.02 [0.99-1.06],0.202999840716143,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,69,0.98 [0.95-1.01],0.203416263246205,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,69,1.02 [0.99-1.05],0.204558853110136,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TLR1,Toll-like receptor 1,Inverse variance weighted,69,1.02 [0.99-1.04],0.205221136300638,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SDC4,Syndecan-4,Inverse variance weighted,69,0.98 [0.95-1.01],0.205388855400834,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD83,CD83 antigen,Inverse variance weighted,69,1.02 [0.99-1.05],0.205592708292837,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,OLFM4,Olfactomedin-4,Inverse variance weighted,69,1.02 [0.99-1.05],0.205953594393802,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CHGB,Secretogranin-1,Inverse variance weighted,69,0.98 [0.95-1.01],0.206202229511452,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,69,1.02 [0.99-1.06],0.206961203307498,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,S100G,Protein S100-G,Inverse variance weighted,69,0.98 [0.96-1.01],0.209394344857899,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,69,1.02 [0.99-1.04],0.20977107742428,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,69,0.98 [0.94-1.01],0.210410880064516,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GM2A,Ganglioside GM2 activator,Inverse variance weighted,69,0.98 [0.96-1.01],0.213638164390334,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,69,1.02 [0.99-1.05],0.214650888145274,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,69,0.98 [0.96-1.01],0.214699926977074,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,Inverse variance weighted,69,1.02 [0.99-1.05],0.21494974150415,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CLSTN2,Calsyntenin-2,Inverse variance weighted,69,1.02 [0.99-1.05],0.215108267136504,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MCFD2,Multiple coagulation factor deficiency protein 2,Inverse variance weighted,69,0.98 [0.96-1.01],0.215269296205181,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DAG1,Dystroglycan,Inverse variance weighted,69,1.02 [0.99-1.05],0.217010998333791,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FDX1,"Adrenodoxin, mitochondrial",Inverse variance weighted,69,1.02 [0.99-1.04],0.2175283550421,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,69,0.98 [0.94-1.01],0.218452596507913,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AKR1B10,Aldo-keto reductase family 1 member B10,Inverse variance weighted,69,1.02 [0.99-1.04],0.219126704897104,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Inverse variance weighted,69,1.02 [0.99-1.05],0.219355568807512,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,Inverse variance weighted,69,1.02 [0.99-1.04],0.221441414262788,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CHGA,Chromogranin-A,Inverse variance weighted,69,0.98 [0.95-1.01],0.223062974494148,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FOLR2,Folate receptor beta,Inverse variance weighted,69,0.98 [0.95-1.01],0.223484996683536,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,69,1.02 [0.99-1.05],0.224645598115343,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VPS37A,Vacuolar protein sorting-associated protein 37A,Inverse variance weighted,69,1.02 [0.99-1.05],0.226800214935094,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,69,0.99 [0.96-1.01],0.226882049635365,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EDN1,Endothelin-1,Inverse variance weighted,69,1.02 [0.99-1.04],0.228233133088709,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,APOA2,Apolipoprotein A-II,Inverse variance weighted,69,0.98 [0.94-1.01],0.228847958216594,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PALM,Paralemmin-1,Inverse variance weighted,69,0.98 [0.94-1.01],0.229767166677045,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL1R2,Interleukin-1 receptor type 2,Inverse variance weighted,69,1.02 [0.99-1.05],0.234537984445907,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CFH,Complement factor H,Inverse variance weighted,69,1.02 [0.99-1.06],0.235616726757976,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KIF22,Kinesin-like protein KIF22,Inverse variance weighted,69,0.98 [0.95-1.01],0.237836118613377,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL25,C-C motif chemokine 25,Inverse variance weighted,69,1.02 [0.99-1.05],0.23812625057464,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LYPD3,Ly6/PLAUR domain-containing protein 3,Inverse variance weighted,69,1.02 [0.99-1.05],0.238664732739853,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,69,0.98 [0.95-1.01],0.239152828917607,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL5,C-C motif chemokine 5,Inverse variance weighted,69,0.98 [0.95-1.01],0.239392801803543,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,69,0.98 [0.95-1.01],0.239545981487249,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KLB,Beta-klotho,Inverse variance weighted,69,0.98 [0.96-1.01],0.240040903317414,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,69,1.02 [0.99-1.04],0.240668789479032,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,QSOX1,Sulfhydryl oxidase 1,Inverse variance weighted,69,1.01 [0.99-1.04],0.241665566221117,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,69,0.96 [0.88-1.03],0.242874498804571,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD36,Platelet glycoprotein 4,Inverse variance weighted,69,1.02 [0.99-1.05],0.243068224613225,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PECAM1,Platelet endothelial cell adhesion molecule,Inverse variance weighted,69,1.01 [0.99-1.04],0.243191210185966,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CRISP2,Cysteine-rich secretory protein 2,Inverse variance weighted,69,0.99 [0.96-1.01],0.244150545952013,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Inverse variance weighted,69,1.01 [0.99-1.04],0.244776546435527,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,69,1.02 [0.99-1.05],0.245264232322836,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,Inverse variance weighted,69,1.02 [0.99-1.04],0.246188661338552,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD8A,T-cell surface glycoprotein CD8 alpha chain,Inverse variance weighted,69,1.01 [0.99-1.04],0.247666989539223,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CFP,Properdin,Inverse variance weighted,69,1.02 [0.99-1.05],0.248646133210669,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,69,0.99 [0.97-1.01],0.24938081696785,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TGFA,Protransforming growth factor alpha,Inverse variance weighted,69,1.02 [0.99-1.05],0.252628548375065,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DCN,Decorin,Inverse variance weighted,69,1.02 [0.99-1.05],0.253414820776215,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Inverse variance weighted,69,1.02 [0.99-1.04],0.254935935672016,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MMP8,Neutrophil collagenase,Inverse variance weighted,69,1.01 [0.99-1.04],0.25610463730028,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CLEC4A,C-type lectin domain family 4 member A,Inverse variance weighted,69,0.98 [0.96-1.01],0.258373445905423,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,69,1.01 [0.99-1.04],0.258764792790829,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,69,0.98 [0.95-1.01],0.261047728431143,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,69,1.02 [0.99-1.05],0.263420901507943,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,69,1.01 [0.99-1.03],0.264684084542223,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PCDH17,Protocadherin-17,Inverse variance weighted,69,1.02 [0.99-1.05],0.267473281826191,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SERPINE1,Plasminogen activator inhibitor 1,Inverse variance weighted,69,1.02 [0.99-1.05],0.267678104740056,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PGA4,Pepsin A-4,Inverse variance weighted,69,1.01 [0.99-1.04],0.271556202549617,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ROBO2,Roundabout homolog 2,Inverse variance weighted,69,1.02 [0.99-1.05],0.276348734502952,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,69,1.02 [0.99-1.05],0.276742548868545,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,69,1.02 [0.99-1.04],0.277008230895106,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,69,0.99 [0.96-1.01],0.277567685501918,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,INSL3,Insulin-like 3,Inverse variance weighted,69,1.01 [0.99-1.02],0.283197543356661,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,Inverse variance weighted,69,0.99 [0.96-1.01],0.283397397721357,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD160,CD160 antigen,Inverse variance weighted,69,1.02 [0.98-1.06],0.284583147419577,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,69,1.02 [0.99-1.04],0.285154833136391,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTPRS,Receptor-type tyrosine-protein phosphatase S,Inverse variance weighted,69,0.98 [0.93-1.02],0.285562525804082,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,69,0.98 [0.96-1.01],0.286787925315582,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MEGF10,Multiple epidermal growth factor-like domains protein 10,Inverse variance weighted,69,0.98 [0.96-1.01],0.287074218893511,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GPC5,Glypican-5,Inverse variance weighted,69,0.98 [0.95-1.01],0.287262463864942,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ROBO1,Roundabout homolog 1,Inverse variance weighted,69,1.02 [0.99-1.05],0.288854733240291,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CSTB,Cystatin-B,Inverse variance weighted,69,1.01 [0.99-1.04],0.289146316292586,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AFP,Alpha-fetoprotein,Inverse variance weighted,69,1.02 [0.99-1.05],0.28929180866496,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PAXX,Protein PAXX,Inverse variance weighted,69,1.02 [0.99-1.05],0.289703743253797,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,Inverse variance weighted,69,1.01 [0.99-1.03],0.290433607024376,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,Inverse variance weighted,69,1.02 [0.98-1.05],0.291425661023321,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GPI,Glucose-6-phosphate isomerase,Inverse variance weighted,69,1.02 [0.99-1.04],0.292404990243467,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CEP43,Centrosomal protein 43,Inverse variance weighted,69,1.02 [0.99-1.04],0.292445061356052,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,69,1.01 [0.99-1.04],0.293264339010421,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,Inverse variance weighted,69,1.01 [0.99-1.04],0.295368817312536,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HYAL1,Hyaluronidase-1,Inverse variance weighted,69,1.02 [0.98-1.06],0.296407492354087,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,69,1.01 [0.99-1.04],0.297011178953803,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,69,1.02 [0.99-1.05],0.298501374251316,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PSME1,Proteasome activator complex subunit 1,Inverse variance weighted,69,1.02 [0.99-1.05],0.299595927719615,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,69,0.94 [0.83-1.06],0.3020699905107,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BECN1,Beclin-1,Inverse variance weighted,69,1.02 [0.99-1.05],0.303630651051602,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,69,1.01 [0.99-1.04],0.303746252664438,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PREB,Prolactin regulatory element-binding protein,Inverse variance weighted,69,1.02 [0.98-1.05],0.303835666918363,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,69,0.99 [0.96-1.01],0.304860115241824,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FGR,Tyrosine-protein kinase Fgr,Inverse variance weighted,69,1.01 [0.99-1.04],0.307317923527454,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TIMP3,Metalloproteinase inhibitor 3,Inverse variance weighted,69,1.01 [0.99-1.04],0.313002635513237,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CTRL,Chymotrypsin-like protease CTRL-1,Inverse variance weighted,69,0.98 [0.94-1.02],0.313080928797158,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,69,1.02 [0.99-1.05],0.31440022551607,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,69,1.01 [0.99-1.03],0.318221751275639,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SIGLEC9,Sialic acid-binding Ig-like lectin 9,Inverse variance weighted,69,1.01 [0.99-1.04],0.318249742999558,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",Inverse variance weighted,69,1.01 [0.99-1.04],0.318258657884777,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,69,1.01 [0.99-1.04],0.318334102166246,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TALDO1,Transaldolase,Inverse variance weighted,69,1.01 [0.99-1.04],0.320687849203094,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,P4HB,Protein disulfide-isomerase,Inverse variance weighted,69,1.02 [0.98-1.05],0.322027092297824,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,69,1.02 [0.99-1.05],0.322333195155962,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,69,1.01 [0.99-1.05],0.326256733942907,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,69,0.98 [0.95-1.02],0.328578443632441,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TAX1BP1,Tax1-binding protein 1,Inverse variance weighted,69,1.01 [0.99-1.04],0.328814713150057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,69,1.01 [0.99-1.04],0.329141298763581,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,69,1.01 [0.99-1.04],0.331352401872474,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,69,1.01 [0.98-1.05],0.332362888301156,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Inverse variance weighted,69,1.01 [0.99-1.04],0.333791853371555,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CALB1,Calbindin,Inverse variance weighted,69,0.99 [0.96-1.01],0.334671349696084,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,69,1.02 [0.98-1.05],0.335209189791307,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PRTG,Protogenin,Inverse variance weighted,69,1.01 [0.99-1.04],0.337443158536394,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,Inverse variance weighted,69,0.99 [0.96-1.02],0.338749556426287,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,69,1.01 [0.99-1.03],0.33935280191182,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PKD2,Polycystin-2,Inverse variance weighted,69,0.99 [0.96-1.01],0.339925191638114,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,Inverse variance weighted,69,1.02 [0.98-1.05],0.341257232675167,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ITGAV,Integrin alpha-V,Inverse variance weighted,69,0.99 [0.96-1.01],0.342067218152057,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ERBB4,Receptor tyrosine-protein kinase erbB-4,Inverse variance weighted,69,1.02 [0.98-1.06],0.342258100310134,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,Inverse variance weighted,69,0.99 [0.96-1.01],0.342359387636564,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCN3,CCN family member 3,Inverse variance weighted,69,0.98 [0.95-1.02],0.342444346326082,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,69,1.02 [0.98-1.05],0.342872035191141,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDA,Cytidine deaminase,Inverse variance weighted,69,1.01 [0.99-1.04],0.343082202231134,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TF,Serotransferrin,Inverse variance weighted,69,1.01 [0.99-1.04],0.345107396469046,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SLITRK6,SLIT and NTRK-like protein 6,Inverse variance weighted,69,0.98 [0.95-1.02],0.345797801673574,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,69,1.02 [0.98-1.05],0.346202741297372,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TYMP,Thymidine phosphorylase,Inverse variance weighted,69,0.99 [0.96-1.01],0.347066463805951,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MUC2,Mucin-2,Inverse variance weighted,69,1.01 [0.99-1.03],0.351062314620084,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ERBB3,Receptor tyrosine-protein kinase erbB-3,Inverse variance weighted,69,1.03 [0.97-1.08],0.351278102790168,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EFNA1,Ephrin-A1,Inverse variance weighted,69,0.99 [0.96-1.01],0.351701779156031,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FOLR1,Folate receptor alpha,Inverse variance weighted,69,0.99 [0.96-1.02],0.351884531132918,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,OMG,Oligodendrocyte-myelin glycoprotein,Inverse variance weighted,69,0.99 [0.96-1.02],0.352470270791464,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,Inverse variance weighted,69,1.01 [0.99-1.04],0.355281744465119,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KLK14,Kallikrein-14,Inverse variance weighted,69,0.99 [0.96-1.01],0.35570932179999,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SPON2,Spondin-2,Inverse variance weighted,69,1.01 [0.98-1.04],0.356036298130384,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,XCL1,Lymphotactin,Inverse variance weighted,69,1.01 [0.99-1.03],0.356325399117073,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,USP28,Ubiquitin carboxyl-terminal hydrolase 28,Inverse variance weighted,69,1.01 [0.99-1.04],0.358668737533355,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FETUB,Fetuin-B,Inverse variance weighted,69,1.02 [0.98-1.05],0.359045765307758,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL17RA,Interleukin-17 receptor A,Inverse variance weighted,69,1.01 [0.99-1.03],0.359920547382377,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FSTL3,Follistatin-related protein 3,Inverse variance weighted,69,0.98 [0.94-1.02],0.360250779128378,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,69,0.99 [0.96-1.02],0.361608077908684,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,69,1.01 [0.99-1.03],0.36190976034076,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GIP,Gastric inhibitory polypeptide,Inverse variance weighted,69,1.01 [0.98-1.04],0.362360652613137,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PDGFC,Platelet-derived growth factor C,Inverse variance weighted,69,1.01 [0.99-1.04],0.362549701700312,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NAGK,N-acetyl-D-glucosamine kinase,Inverse variance weighted,69,0.99 [0.96-1.02],0.36316701351135,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TFF3,Trefoil factor 3,Inverse variance weighted,69,1.01 [0.99-1.04],0.36780986685015,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,69,1.01 [0.99-1.03],0.369068393846697,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BSG,Basigin,Inverse variance weighted,69,0.98 [0.95-1.02],0.369701834066011,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CST6,Cystatin-M,Inverse variance weighted,69,0.98 [0.95-1.02],0.370716535927979,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,69,1.01 [0.98-1.04],0.376204635109874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FGFBP2,Fibroblast growth factor-binding protein 2,Inverse variance weighted,69,1.01 [0.98-1.04],0.377918524898429,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LPCAT2,Lysophosphatidylcholine acyltransferase 2,Inverse variance weighted,69,1.01 [0.99-1.04],0.379279194262364,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,69,1.01 [0.98-1.05],0.379474909748238,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MILR1,Allergin-1,Inverse variance weighted,69,1.01 [0.98-1.04],0.381826939257878,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,69,1.01 [0.99-1.04],0.382669135691969,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,Inverse variance weighted,69,1.01 [0.99-1.04],0.382727549611989,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,69,1.01 [0.98-1.04],0.384358172442682,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CA9,Carbonic anhydrase 9,Inverse variance weighted,69,1.01 [0.98-1.04],0.38765768630437,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RNASE6,Ribonuclease K6,Inverse variance weighted,69,1.01 [0.98-1.04],0.388653202238925,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDH3,Cadherin-3,Inverse variance weighted,69,0.98 [0.95-1.02],0.388686772079302,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EPCAM,Epithelial cell adhesion molecule,Inverse variance weighted,69,0.99 [0.96-1.02],0.391251201768998,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ABCA2,ATP-binding cassette sub-family A member 2,Inverse variance weighted,69,1.01 [0.99-1.04],0.392563731177169,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FABP5,Fatty acid-binding protein 5,Inverse variance weighted,69,1.01 [0.99-1.04],0.392930875178843,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,69,0.99 [0.96-1.01],0.393375404417263,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PPP1R9B,Neurabin-2,Inverse variance weighted,69,1.01 [0.99-1.04],0.393962044849391,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SETMAR,Histone-lysine N-methyltransferase SETMAR,Inverse variance weighted,69,0.99 [0.96-1.02],0.395321319914761,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NPPB,Natriuretic peptides B,Inverse variance weighted,69,0.99 [0.97-1.01],0.396670905270981,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,S100A14,Protein S100-A14,Inverse variance weighted,69,0.99 [0.96-1.02],0.397678228229551,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CLMP,CXADR-like membrane protein,Inverse variance weighted,69,0.98 [0.94-1.02],0.402819844846948,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GDF2,Growth/differentiation factor 2,Inverse variance weighted,69,1.01 [0.98-1.05],0.407366503230862,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD300E,CMRF35-like molecule 2,Inverse variance weighted,69,0.99 [0.96-1.02],0.407530889762032,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,THBS4,Thrombospondin-4,Inverse variance weighted,69,1.01 [0.98-1.05],0.408728570652087,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,69,1.01 [0.99-1.04],0.409360506638476,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CTSC,Dipeptidyl peptidase 1,Inverse variance weighted,69,1.01 [0.99-1.03],0.410067042222818,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PI3,Elafin,Inverse variance weighted,69,1.01 [0.98-1.04],0.412706287163691,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SERPINH1,Serpin H1,Inverse variance weighted,69,1.01 [0.98-1.04],0.413529766889823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LGALS3,Galectin-3,Inverse variance weighted,69,1.01 [0.98-1.05],0.414171408765458,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,69,1.01 [0.98-1.05],0.414523548957147,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,COL3A1,Collagen alpha-1(III) chain,Inverse variance weighted,69,1.01 [0.98-1.04],0.416710339072681,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RNASET2,Ribonuclease T2,Inverse variance weighted,69,1.01 [0.99-1.04],0.417327143542862,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,69,1.01 [0.98-1.04],0.41770607933507,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,S100A16,Protein S100-A16,Inverse variance weighted,69,0.99 [0.96-1.02],0.418184573881063,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,INSR,Insulin receptor,Inverse variance weighted,69,0.99 [0.96-1.02],0.418674746392095,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADGRE1,Adhesion G protein-coupled receptor E1,Inverse variance weighted,69,1.01 [0.98-1.04],0.421972903730093,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BPIFB1,BPI fold-containing family B member 1,Inverse variance weighted,69,0.99 [0.96-1.02],0.423838742458107,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MMP1,Interstitial collagenase,Inverse variance weighted,69,0.99 [0.96-1.02],0.42565549151042,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,69,1.01 [0.98-1.04],0.42815690129643,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,69,0.99 [0.96-1.02],0.429724684129812,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RETN,Resistin,Inverse variance weighted,69,0.99 [0.95-1.02],0.430710416334559,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,69,1.01 [0.98-1.04],0.431464049750018,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD109,CD109 antigen,Inverse variance weighted,69,1.01 [0.99-1.03],0.433592659151824,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SEL1L,Protein sel-1 homolog 1,Inverse variance weighted,69,1.01 [0.99-1.03],0.434705205290999,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ULBP2,UL16-binding protein 2,Inverse variance weighted,69,1.01 [0.99-1.03],0.435398616022317,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,69,0.99 [0.97-1.01],0.436249372484514,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,F9,Coagulation factor IX,Inverse variance weighted,69,1.02 [0.97-1.07],0.436858133376197,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,69,0.99 [0.95-1.02],0.43735622138501,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,69,0.99 [0.96-1.02],0.438688674694236,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CEP20,Centrosomal protein 20,Inverse variance weighted,69,1.01 [0.98-1.04],0.441356498635461,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDH6,Cadherin-6,Inverse variance weighted,69,0.99 [0.96-1.02],0.442999033230549,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MMP10,Stromelysin-2,Inverse variance weighted,69,0.99 [0.97-1.02],0.443864507837858,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BTN2A1,Butyrophilin subfamily 2 member A1,Inverse variance weighted,69,0.99 [0.96-1.02],0.444659701256968,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,Inverse variance weighted,69,1.01 [0.98-1.05],0.446008312864789,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,69,1.01 [0.98-1.05],0.446534640737975,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,Inverse variance weighted,69,1.01 [0.98-1.04],0.446899945767715,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TFRC,Transferrin receptor protein 1,Inverse variance weighted,69,0.99 [0.96-1.02],0.447299807110436,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NIT2,Omega-amidase NIT2,Inverse variance weighted,69,1.01 [0.98-1.04],0.44733164837852,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,69,1.01 [0.98-1.04],0.449978014446028,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,69,1.01 [0.98-1.05],0.450277634797736,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,69,1.01 [0.98-1.03],0.450976754140593,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BCAM,Basal cell adhesion molecule,Inverse variance weighted,69,0.99 [0.96-1.02],0.451472705299717,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,69,1.01 [0.98-1.05],0.453114579202867,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PDCD1,Programmed cell death protein 1,Inverse variance weighted,69,0.99 [0.96-1.02],0.453317202225762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLIN3,Perilipin-3,Inverse variance weighted,69,0.99 [0.96-1.02],0.453447212456818,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VWC2,Brorin,Inverse variance weighted,69,0.99 [0.96-1.02],0.454256075635383,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,F11R,Junctional adhesion molecule A,Inverse variance weighted,69,1.01 [0.98-1.05],0.456714522038261,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HHEX,Hematopoietically-expressed homeobox protein HHEX,Inverse variance weighted,69,1.01 [0.98-1.05],0.45693723817129,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DTNB,Dystrobrevin beta,Inverse variance weighted,69,1.01 [0.98-1.04],0.45747705435669,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CFI,Complement factor I,Inverse variance weighted,69,1.02 [0.97-1.06],0.457908731271485,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL10,Interleukin-10,Inverse variance weighted,69,1.01 [0.98-1.04],0.458615667612781,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,69,1.01 [0.98-1.04],0.458908995776603,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,WFDC1,WAP four-disulfide core domain protein 1,Inverse variance weighted,69,1.01 [0.98-1.04],0.4605078699833,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FAM3C,Protein FAM3C,Inverse variance weighted,69,1.01 [0.98-1.04],0.46102998976865,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,69,1.01 [0.98-1.04],0.461583947083084,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,69,0.99 [0.96-1.02],0.461640658323114,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SPOCK1,Testican-1,Inverse variance weighted,69,0.99 [0.96-1.02],0.466716931962055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SMAD5,Mothers against decapentaplegic homolog 5,Inverse variance weighted,69,1.01 [0.98-1.04],0.467227959901868,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RBP7,Retinoid-binding protein 7,Inverse variance weighted,69,1.01 [0.98-1.04],0.468084451222708,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ANXA10,Annexin A10,Inverse variance weighted,69,1.01 [0.98-1.03],0.469115147846027,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SELP,P-selectin,Inverse variance weighted,69,1.01 [0.98-1.04],0.471410913868122,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GFRA3,GDNF family receptor alpha-3,Inverse variance weighted,69,1.01 [0.98-1.04],0.475322593284856,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CX3CL1,Fractalkine,Inverse variance weighted,69,0.99 [0.95-1.02],0.47671357076853,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PSME2,Proteasome activator complex subunit 2,Inverse variance weighted,69,1.01 [0.98-1.04],0.480144927780593,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ANPEP,Aminopeptidase N,Inverse variance weighted,69,0.99 [0.96-1.02],0.481268322700744,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,69,1.01 [0.98-1.04],0.485111944472859,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,69,0.99 [0.97-1.02],0.485286971419862,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,69,1.01 [0.98-1.04],0.48726703270723,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL14,C-C motif chemokine 14,Inverse variance weighted,69,0.99 [0.97-1.02],0.48927161539089,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,69,1.01 [0.98-1.05],0.489857551788673,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,69,1.01 [0.98-1.03],0.491061745216768,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL28,C-C motif chemokine 28,Inverse variance weighted,69,1.01 [0.98-1.04],0.494951031218882,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,POF1B,Protein POF1B,Inverse variance weighted,69,0.99 [0.97-1.02],0.495538324646552,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ZBTB17,Zinc finger and BTB domain-containing protein 17,Inverse variance weighted,69,1.01 [0.98-1.04],0.496647919603235,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PRSS27,Serine protease 27,Inverse variance weighted,69,1.01 [0.98-1.03],0.502226125939465,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NUCB2,Nucleobindin-2,Inverse variance weighted,69,0.97 [0.88-1.06],0.50243814652802,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GAST,Gastrin,Inverse variance weighted,69,1.01 [0.98-1.04],0.504321253069154,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DNMBP,Dynamin-binding protein,Inverse variance weighted,69,1.01 [0.98-1.04],0.504371591922232,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CNTNAP2,Contactin-associated protein-like 2,Inverse variance weighted,69,1.01 [0.98-1.04],0.504535435670421,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CST3,Cystatin-C,Inverse variance weighted,69,1.01 [0.98-1.04],0.507870200717155,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PRSS2,Trypsin-2,Inverse variance weighted,69,0.99 [0.95-1.02],0.508205776967434,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SEPTIN8,Septin-8,Inverse variance weighted,69,1.01 [0.98-1.03],0.510653315719296,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLG,Plasminogen,Inverse variance weighted,69,0.99 [0.95-1.03],0.511250741698787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SEZ6L,Seizure 6-like protein,Inverse variance weighted,69,0.99 [0.96-1.02],0.511469958107944,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,69,0.99 [0.96-1.02],0.51639936121927,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IMMT,MICOS complex subunit MIC60,Inverse variance weighted,69,1.01 [0.98-1.04],0.51813651334926,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BLMH,Bleomycin hydrolase,Inverse variance weighted,69,0.99 [0.97-1.02],0.520035215494182,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AKAP12,A-kinase anchor protein 12,Inverse variance weighted,69,0.99 [0.96-1.02],0.520636411234231,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,THBS2,Thrombospondin-2,Inverse variance weighted,69,1.01 [0.98-1.04],0.521383167808669,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FAM3B,Protein FAM3B,Inverse variance weighted,69,1.01 [0.98-1.03],0.521807052511957,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,69,1.01 [0.98-1.04],0.524341299740893,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,69,1.01 [0.98-1.04],0.526053295016559,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NUDT5,ADP-sugar pyrophosphatase,Inverse variance weighted,69,1.01 [0.98-1.05],0.527751068534958,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GIGYF2,GRB10-interacting GYF protein 2,Inverse variance weighted,69,0.99 [0.96-1.02],0.533796415868119,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SERPINB8,Serpin B8,Inverse variance weighted,69,1.01 [0.98-1.03],0.534085639536501,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EEF1D,Elongation factor 1-delta,Inverse variance weighted,69,1.01 [0.98-1.04],0.535196037513385,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,69,0.99 [0.97-1.02],0.535838183387703,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CRYBB2,Beta-crystallin B2,Inverse variance weighted,69,0.99 [0.96-1.02],0.536434389895489,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MTDH,Protein LYRIC,Inverse variance weighted,69,1.01 [0.98-1.04],0.537164959331926,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LMNB2,Lamin-B2,Inverse variance weighted,69,0.99 [0.96-1.02],0.53758063825038,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLEKHO1,Pleckstrin homology domain-containing family O member 1,Inverse variance weighted,69,1.01 [0.98-1.04],0.537730968972093,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD302,CD302 antigen,Inverse variance weighted,69,1.01 [0.98-1.04],0.537774076025828,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,69,1.01 [0.98-1.04],0.538420551667887,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,69,1.01 [0.98-1.04],0.538544294697244,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ALCAM,CD166 antigen,Inverse variance weighted,69,0.99 [0.96-1.02],0.538986998948886,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SERPIND1,Heparin cofactor 2,Inverse variance weighted,69,1.01 [0.97-1.06],0.541346168055855,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,69,1.01 [0.98-1.03],0.541915027187204,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RASSF2,Ras association domain-containing protein 2,Inverse variance weighted,69,1.01 [0.98-1.04],0.54197754866841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,69,1.01 [0.98-1.03],0.546727390984326,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GPA33,Cell surface A33 antigen,Inverse variance weighted,69,0.99 [0.96-1.02],0.546775227440263,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,Inverse variance weighted,69,1.01 [0.98-1.04],0.547582469610758,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SORT1,Sortilin,Inverse variance weighted,69,1.01 [0.98-1.04],0.547986513507259,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,69,0.99 [0.96-1.02],0.548881698612069,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FGF5,Fibroblast growth factor 5,Inverse variance weighted,69,1.01 [0.98-1.03],0.550383104441551,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,69,0.99 [0.97-1.02],0.550421043251602,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,Inverse variance weighted,69,1.01 [0.98-1.04],0.554412824996468,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FSTL1,Follistatin-related protein 1,Inverse variance weighted,69,0.99 [0.95-1.03],0.555679958609974,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,69,0.99 [0.97-1.02],0.557218958123554,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CAPG,Macrophage-capping protein,Inverse variance weighted,69,1.01 [0.98-1.03],0.558297795109898,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,69,0.99 [0.96-1.02],0.559032456465475,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,69,1.01 [0.98-1.04],0.559424625259548,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RCC1,Regulator of chromosome condensation,Inverse variance weighted,69,1.01 [0.98-1.03],0.560394392383899,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FASLG,Tumor necrosis factor ligand superfamily member 6,Inverse variance weighted,69,0.99 [0.94-1.03],0.562471025908074,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,69,1.01 [0.98-1.04],0.564762516912527,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,Inverse variance weighted,69,1.01 [0.98-1.04],0.566969957846763,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,69,1.01 [0.98-1.03],0.569124296702895,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TXLNA,Alpha-taxilin,Inverse variance weighted,69,1.01 [0.98-1.04],0.571743601474785,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,69,1.01 [0.98-1.03],0.571961078474484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ASAH1,Acid ceramidase,Inverse variance weighted,69,0.99 [0.97-1.02],0.573238140010666,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HSPA1A,Heat shock 70 kDa protein 1A,Inverse variance weighted,69,1.01 [0.98-1.04],0.573641495029009,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",Inverse variance weighted,69,0.99 [0.97-1.02],0.575546443902361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,69,1.01 [0.98-1.04],0.576169725870501,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD59,CD59 glycoprotein,Inverse variance weighted,69,0.99 [0.96-1.02],0.579575489647351,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DSC2,Desmocollin-2,Inverse variance weighted,69,0.99 [0.96-1.02],0.58199750328015,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TACSTD2,Tumor-associated calcium signal transducer 2,Inverse variance weighted,69,1.01 [0.98-1.04],0.583340860262199,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TOP2B,DNA topoisomerase 2-beta,Inverse variance weighted,69,1.01 [0.98-1.03],0.584175367476868,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,69,0.99 [0.97-1.02],0.585067466786095,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,69,1.01 [0.98-1.03],0.585796778857994,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFSF14,Tumor necrosis factor ligand superfamily member 14,Inverse variance weighted,69,1.01 [0.98-1.04],0.586715298389,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,69,0.99 [0.97-1.02],0.586718068844911,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SLMAP,Sarcolemmal membrane-associated protein,Inverse variance weighted,69,0.99 [0.97-1.02],0.590847074383455,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FAM3D,Protein FAM3D,Inverse variance weighted,69,1.01 [0.98-1.03],0.59274703843128,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FABP6,Gastrotropin,Inverse variance weighted,69,0.99 [0.97-1.02],0.59284781702142,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,OBP2B,Odorant-binding protein 2b,Inverse variance weighted,69,0.99 [0.97-1.02],0.59576591805195,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FCRLB,Fc receptor-like B,Inverse variance weighted,69,1.01 [0.98-1.03],0.595840073061487,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,69,1.01 [0.98-1.04],0.596286526664264,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,REG1B,Lithostathine-1-beta,Inverse variance weighted,69,1.01 [0.98-1.03],0.59651010244884,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,69,1.01 [0.97-1.05],0.59688023721848,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HPSE,Heparanase,Inverse variance weighted,69,0.99 [0.97-1.02],0.600156308448515,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SERPINA7,Thyroxine-binding globulin,Inverse variance weighted,69,0.99 [0.96-1.02],0.604798659891442,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Inverse variance weighted,69,1.01 [0.98-1.04],0.608990580707333,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,69,1.01 [0.97-1.06],0.612414635847528,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,69,1.01 [0.98-1.03],0.612862094563348,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,69,0.99 [0.96-1.03],0.614165665625435,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,69,0.99 [0.97-1.02],0.614623326080318,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HEXIM1,Protein HEXIM1,Inverse variance weighted,69,1.01 [0.98-1.04],0.614691766938088,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KLK4,Kallikrein-4,Inverse variance weighted,69,1.01 [0.98-1.03],0.614957722827511,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RNASE4,Ribonuclease 4,Inverse variance weighted,69,1.01 [0.97-1.05],0.616997727088512,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KLK3,Prostate-specific antigen,Inverse variance weighted,69,1 [0.99-1.02],0.617845293956842,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,69,1.01 [0.98-1.04],0.618764232817213,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PGF,Placenta growth factor,Inverse variance weighted,69,1.01 [0.98-1.04],0.621827344293665,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SEMA3F,Semaphorin-3F,Inverse variance weighted,69,0.99 [0.94-1.04],0.622022777408837,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,69,1.01 [0.98-1.04],0.622801415164991,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",Inverse variance weighted,69,0.99 [0.97-1.02],0.623122621375593,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,69,1.01 [0.98-1.04],0.623404655050986,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Inverse variance weighted,69,0.99 [0.95-1.03],0.623577122843483,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,69,0.99 [0.97-1.02],0.623861851969793,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,69,0.99 [0.96-1.02],0.624765284062491,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PSAP,Prosaposin,Inverse variance weighted,69,1.01 [0.98-1.03],0.62530197641295,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,Inverse variance weighted,69,1.01 [0.98-1.03],0.625586097889079,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,69,1.01 [0.98-1.04],0.625837791262742,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LIF,Leukemia inhibitory factor,Inverse variance weighted,69,1.01 [0.98-1.03],0.626826856911787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD27,CD27 antigen,Inverse variance weighted,69,1.01 [0.98-1.04],0.627106720288879,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GBP1,Guanylate-binding protein 1,Inverse variance weighted,69,1.01 [0.98-1.04],0.629092832605836,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,69,0.99 [0.96-1.02],0.630335508743154,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,69,1.01 [0.98-1.03],0.631529632727653,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,69,0.99 [0.97-1.02],0.631959927447719,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,Inverse variance weighted,69,0.99 [0.96-1.02],0.634186422193535,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MARCO,Macrophage receptor MARCO,Inverse variance weighted,69,1.01 [0.98-1.04],0.635199506099989,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ALPP,"Alkaline phosphatase, placental type",Inverse variance weighted,69,0.99 [0.97-1.02],0.635426930705944,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ERP44,Endoplasmic reticulum resident protein 44,Inverse variance weighted,69,1.01 [0.98-1.04],0.636680263725154,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,69,0.99 [0.97-1.02],0.63748163041533,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VNN2,Vascular non-inflammatory molecule 2,Inverse variance weighted,69,1.01 [0.98-1.03],0.638679894356099,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,69,0.99 [0.96-1.02],0.639094801101754,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,69,1.01 [0.97-1.05],0.640949893348019,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,69,0.99 [0.97-1.02],0.643437600408126,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,69,1.01 [0.98-1.03],0.645611610515157,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD300C,CMRF35-like molecule 6,Inverse variance weighted,69,0.99 [0.97-1.02],0.64717292677314,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",Inverse variance weighted,69,1.01 [0.98-1.04],0.648308142264115,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,69,1.01 [0.97-1.05],0.648578736126539,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ANGPT2,Angiopoietin-2,Inverse variance weighted,69,1.01 [0.97-1.04],0.649031239131624,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TXNDC5,Thioredoxin domain-containing protein 5,Inverse variance weighted,69,0.99 [0.97-1.02],0.649182594738463,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,Inverse variance weighted,69,1.01 [0.98-1.04],0.649828258917563,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,POSTN,Periostin,Inverse variance weighted,69,0.99 [0.96-1.02],0.65097311811607,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DNAJA2,DnaJ homolog subfamily A member 2,Inverse variance weighted,69,1.01 [0.98-1.04],0.653512740745602,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RALY,RNA-binding protein Raly,Inverse variance weighted,69,1.01 [0.98-1.03],0.654106060696845,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,C1RL,Complement C1r subcomponent-like protein,Inverse variance weighted,69,1.01 [0.98-1.04],0.655445822201339,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IDS,Iduronate 2-sulfatase,Inverse variance weighted,69,1.01 [0.98-1.04],0.660706897590108,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",Inverse variance weighted,69,1.01 [0.98-1.04],0.666770639216779,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,69,1 [0.97-1.02],0.667975597424472,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,69,1.01 [0.98-1.03],0.66805047929467,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADA,Adenosine deaminase,Inverse variance weighted,69,1.01 [0.98-1.03],0.668415695557632,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GPC1,Glypican-1,Inverse variance weighted,69,1.01 [0.97-1.04],0.675272945060364,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,69,1.01 [0.98-1.03],0.676245185694911,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,69,0.99 [0.97-1.02],0.677577309841234,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,69,0.99 [0.97-1.02],0.678437560723879,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,69,0.99 [0.96-1.02],0.679713040900632,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SUSD4,Sushi domain-containing protein 4,Inverse variance weighted,69,0.99 [0.97-1.02],0.682286806468116,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FGF23,Fibroblast growth factor 23,Inverse variance weighted,69,1.01 [0.98-1.04],0.683266517132388,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FSHB,Follitropin subunit beta,Inverse variance weighted,69,1 [0.99-1.02],0.683814820889387,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,69,0.99 [0.96-1.03],0.684394396575656,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,69,0.99 [0.97-1.02],0.68688504619994,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,69,1.01 [0.98-1.04],0.687249652004517,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ITGA2,Integrin alpha-2,Inverse variance weighted,69,1 [0.97-1.02],0.688758606784514,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,F7,Coagulation factor VII,Inverse variance weighted,69,1.01 [0.96-1.07],0.690155411256518,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,COLEC12,Collectin-12,Inverse variance weighted,69,0.99 [0.96-1.02],0.692194532617807,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LATS1,Serine/threonine-protein kinase LATS1,Inverse variance weighted,69,1.01 [0.98-1.04],0.692424395110526,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,69,0.99 [0.96-1.03],0.694620089221721,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Inverse variance weighted,69,0.99 [0.96-1.03],0.695309904612518,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTX3,Pentraxin-related protein PTX3,Inverse variance weighted,69,0.99 [0.97-1.02],0.698939030179686,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SLAMF6,SLAM family member 6,Inverse variance weighted,69,1.01 [0.98-1.04],0.699795431045285,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LONP1,"Lon protease homolog, mitochondrial",Inverse variance weighted,69,1 [0.97-1.02],0.702570048275688,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ARSB,Arylsulfatase B,Inverse variance weighted,69,1.01 [0.98-1.03],0.703562476084728,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,69,0.99 [0.96-1.03],0.703655926897124,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,69,1.01 [0.97-1.04],0.705381510778961,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CNTN4,Contactin-4,Inverse variance weighted,69,1 [0.97-1.02],0.706621317036378,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DDR1,Epithelial discoidin domain-containing receptor 1,Inverse variance weighted,69,0.99 [0.96-1.02],0.709019831245197,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,69,1.01 [0.97-1.04],0.710989940228139,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ECHS1,"Enoyl-CoA hydratase, mitochondrial",Inverse variance weighted,69,1 [0.98-1.03],0.712829699988651,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CR1,Complement receptor type 1,Inverse variance weighted,69,1.01 [0.98-1.04],0.712832217867864,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,69,1 [0.97-1.02],0.712924001841457,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,69,0.99 [0.96-1.03],0.713789835180704,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DLL1,Delta-like protein 1,Inverse variance weighted,69,0.99 [0.96-1.02],0.714199824259169,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,69,1.01 [0.97-1.04],0.7143135121044,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,69,1.01 [0.98-1.04],0.719700099236966,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,69,1 [0.98-1.03],0.719993574019674,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LCN15,Lipocalin-15,Inverse variance weighted,69,1.01 [0.97-1.04],0.725793430079413,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD300A,CMRF35-like molecule 8,Inverse variance weighted,69,1 [0.98-1.03],0.728763233378408,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,69,1.01 [0.96-1.05],0.729230582015385,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TGFBI,Transforming growth factor-beta-induced protein ig-h3,Inverse variance weighted,69,0.99 [0.96-1.03],0.730355162943926,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PSIP1,PC4 and SFRS1-interacting protein,Inverse variance weighted,69,1 [0.98-1.03],0.730798535701822,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,69,0.99 [0.97-1.02],0.731957867038875,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SLC27A4,Long-chain fatty acid transport protein 4,Inverse variance weighted,69,1 [0.97-1.02],0.733456470063279,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,69,1.01 [0.98-1.04],0.735375195870873,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,69,0.99 [0.96-1.03],0.735642768416763,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HDGFL2,Hepatoma-derived growth factor-related protein 2,Inverse variance weighted,69,1 [0.98-1.03],0.739232360460321,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,69,1 [0.98-1.03],0.74364930958814,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MB,Myoglobin,Inverse variance weighted,69,1 [0.98-1.04],0.746320582992801,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,69,0.99 [0.96-1.03],0.746356809156997,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,69,1 [0.97-1.02],0.747479351349336,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GFER,FAD-linked sulfhydryl oxidase ALR,Inverse variance weighted,69,1 [0.98-1.03],0.747701536354523,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,69,0.99 [0.96-1.03],0.747713086410152,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CLGN,Calmegin,Inverse variance weighted,69,1 [0.97-1.02],0.747819564099477,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SCGN,Secretagogin,Inverse variance weighted,69,1.01 [0.97-1.04],0.752016633792437,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DPP7,Dipeptidyl peptidase 2,Inverse variance weighted,69,1 [0.97-1.02],0.75357541953896,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,69,1.01 [0.96-1.06],0.755005361462615,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,Inverse variance weighted,69,1 [0.98-1.03],0.755100928894915,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CALB2,Calretinin,Inverse variance weighted,69,1 [0.97-1.04],0.760119074826091,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,69,1 [0.98-1.03],0.760957809807742,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PPY,Pancreatic prohormone,Inverse variance weighted,69,1.01 [0.96-1.06],0.762341645597379,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NPTX1,Neuronal pentraxin-1,Inverse variance weighted,69,1 [0.98-1.03],0.763121819497484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GRN,Progranulin,Inverse variance weighted,69,1 [0.97-1.02],0.764697695794499,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SLIT2,Slit homolog 2 protein,Inverse variance weighted,69,1 [0.97-1.03],0.765486898171701,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,Inverse variance weighted,69,1 [0.98-1.03],0.765790249120898,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GNPDA2,Glucosamine-6-phosphate isomerase 2,Inverse variance weighted,69,1 [0.97-1.04],0.770491646773035,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,69,1 [0.98-1.03],0.771743737255526,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FYB1,FYN-binding protein 1,Inverse variance weighted,69,1 [0.97-1.04],0.772352792295825,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NEFL,Neurofilament light polypeptide,Inverse variance weighted,69,1 [0.98-1.03],0.772649094902206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IQGAP2,Ras GTPase-activating-like protein IQGAP2,Inverse variance weighted,69,1 [0.97-1.03],0.773466429072288,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL21,C-C motif chemokine 21,Inverse variance weighted,69,0.99 [0.96-1.03],0.774056585181112,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,69,0.99 [0.96-1.03],0.7753094028371,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CRNN,Cornulin,Inverse variance weighted,69,1 [0.97-1.02],0.777527821364209,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ACTA2,"Actin, aortic smooth muscle",Inverse variance weighted,69,1 [0.98-1.03],0.778358990084233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL15,Interleukin-15,Inverse variance weighted,69,1 [0.96-1.03],0.77850651990357,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NRP1,Neuropilin-1,Inverse variance weighted,69,1.01 [0.97-1.04],0.780519179116953,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Inverse variance weighted,69,1 [0.98-1.03],0.781179186675718,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SCAMP3,Secretory carrier-associated membrane protein 3,Inverse variance weighted,69,1 [0.97-1.03],0.781196161755616,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADM,Pro-adrenomedullin,Inverse variance weighted,69,1.01 [0.97-1.04],0.782029231648376,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,THBD,Thrombomodulin,Inverse variance weighted,69,1 [0.96-1.03],0.789603121717323,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NECTIN2,Nectin-2,Inverse variance weighted,69,1 [0.97-1.02],0.79126050049325,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,JAM2,Junctional adhesion molecule B,Inverse variance weighted,69,1 [0.97-1.04],0.791764354165814,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MYOC,Myocilin,Inverse variance weighted,69,1 [0.97-1.02],0.799798591575365,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,69,1 [0.97-1.02],0.800282710689725,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,69,1 [0.98-1.03],0.80246092175099,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,Inverse variance weighted,69,1 [0.97-1.03],0.80583296707629,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,69,1 [0.97-1.02],0.807839744204876,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCN5,CCN family member 5,Inverse variance weighted,69,1 [0.97-1.03],0.811578072525646,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SRPK2,SRSF protein kinase 2,Inverse variance weighted,69,1 [0.98-1.03],0.81308499576939,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AKR1C4,Aldo-keto reductase family 1 member C4,Inverse variance weighted,69,1 [0.98-1.03],0.816053045713355,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,B2M,Beta-2-microglobulin,Inverse variance weighted,69,1 [0.97-1.03],0.816852176744869,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AP1G2,AP-1 complex subunit gamma-like 2,Inverse variance weighted,69,1 [0.98-1.03],0.817726579188567,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,69,1 [0.96-1.03],0.818687855275756,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,XG,Glycoprotein Xg,Inverse variance weighted,69,1 [0.98-1.03],0.819329461070365,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,69,1 [0.97-1.04],0.820484233442672,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FN1,Fibronectin,Inverse variance weighted,69,1 [0.98-1.03],0.826852983940894,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ECI2,Enoyl-CoA delta isomerase 2,Inverse variance weighted,69,1 [0.97-1.02],0.827589005918758,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",Inverse variance weighted,69,1 [0.97-1.03],0.830769046742871,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CALCA,Calcitonin,Inverse variance weighted,69,1 [0.97-1.03],0.833901319685631,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,69,1 [0.98-1.03],0.835186698532419,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TDRKH,Tudor and KH domain-containing protein,Inverse variance weighted,69,1 [0.97-1.03],0.836291706681622,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",Inverse variance weighted,69,1 [0.97-1.02],0.837239524073138,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NUMB,Protein numb homolog,Inverse variance weighted,69,1 [0.97-1.03],0.838335864776637,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,69,1 [0.97-1.04],0.838508842042358,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HSPB6,Heat shock protein beta-6,Inverse variance weighted,69,1 [0.97-1.03],0.838580014781386,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LAT,Linker for activation of T-cells family member 1,Inverse variance weighted,69,1 [0.97-1.03],0.839009401831475,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MOCS2,Molybdopterin synthase catalytic subunit,Inverse variance weighted,69,1 [0.97-1.03],0.841268186705139,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CTSL,Cathepsin L1,Inverse variance weighted,69,1 [0.97-1.03],0.844157782862056,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IPCEF1,Interactor protein for cytohesin exchange factors 1,Inverse variance weighted,69,1 [0.98-1.03],0.844281657624096,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FCN2,Ficolin-2,Inverse variance weighted,69,1 [0.97-1.03],0.846693805359548,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CREG1,Protein CREG1,Inverse variance weighted,69,1 [0.98-1.03],0.847925304416914,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EPO,Erythropoietin,Inverse variance weighted,69,1 [0.97-1.03],0.848478181878459,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BMP6,Bone morphogenetic protein 6,Inverse variance weighted,69,1 [0.97-1.02],0.849933841977169,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GAL,Galanin peptides,Inverse variance weighted,69,1 [0.97-1.04],0.853620369306031,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ABL1,Tyrosine-protein kinase ABL1,Inverse variance weighted,69,1 [0.97-1.03],0.853740544961061,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,69,1 [0.98-1.03],0.853891200132683,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MPO,Myeloperoxidase,Inverse variance weighted,69,1 [0.97-1.03],0.854533622535282,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LEP,Leptin,Inverse variance weighted,69,1 [0.96-1.04],0.855283498718833,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,69,1 [0.97-1.03],0.856019250374373,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD6,T-cell differentiation antigen CD6,Inverse variance weighted,69,1 [0.98-1.03],0.859873354240997,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,Inverse variance weighted,69,1 [0.97-1.02],0.862249492040845,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ESYT2,Extended synaptotagmin-2,Inverse variance weighted,69,1 [0.98-1.03],0.866555008320641,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PNLIPRP1,Inactive pancreatic lipase-related protein 1,Inverse variance weighted,69,1 [0.97-1.04],0.868376289521545,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CSF2,Granulocyte-macrophage colony-stimulating factor,Inverse variance weighted,69,1 [0.98-1.03],0.868892833920678,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,69,1 [0.97-1.03],0.873842860613391,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,69,1 [0.97-1.02],0.874529651856651,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CCL18,C-C motif chemokine 18,Inverse variance weighted,69,1 [0.98-1.03],0.874910197261533,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,Inverse variance weighted,69,1 [0.97-1.02],0.876796425381884,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PCDH7,Protocadherin-7,Inverse variance weighted,69,1 [0.97-1.02],0.876930061371077,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,69,1 [0.96-1.05],0.877127607730366,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,Inverse variance weighted,69,1 [0.97-1.03],0.877987288935169,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,69,1 [0.97-1.04],0.87842787439979,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,69,1 [0.97-1.03],0.879113087542322,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,69,1 [0.97-1.03],0.879808217549641,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SHISA5,Protein shisa-5,Inverse variance weighted,69,1 [0.97-1.04],0.880112502856481,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,69,1 [0.97-1.02],0.88086880929549,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SDC1,Syndecan-1,Inverse variance weighted,69,1 [0.97-1.04],0.881132728366762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PENK,Proenkephalin-A,Inverse variance weighted,69,1 [0.97-1.02],0.881706603770298,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,69,1 [0.97-1.02],0.882260143248133,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,APOL1,Apolipoprotein L1,Inverse variance weighted,69,1 [0.97-1.03],0.886259492282765,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,69,1 [0.97-1.03],0.887193656772863,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,Inverse variance weighted,69,1 [0.97-1.03],0.890148828027867,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BAG3,BAG family molecular chaperone regulator 3,Inverse variance weighted,69,1 [0.97-1.03],0.893292924244376,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AMIGO2,Amphoterin-induced protein 2,Inverse variance weighted,69,1 [0.97-1.03],0.894044039124554,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PRDX6,Peroxiredoxin-6,Inverse variance weighted,69,1 [0.98-1.03],0.894202895348877,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DPT,Dermatopontin,Inverse variance weighted,69,1 [0.97-1.03],0.894910241187339,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CPA2,Carboxypeptidase A2,Inverse variance weighted,69,1 [0.97-1.03],0.896305576716699,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GIMAP7,GTPase IMAP family member 7,Inverse variance weighted,69,1 [0.97-1.02],0.89640622742698,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,69,1 [0.96-1.03],0.898442956627675,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CR2,Complement receptor type 2,Inverse variance weighted,69,1 [0.97-1.04],0.903850259894919,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,Inverse variance weighted,69,1 [0.97-1.04],0.907690466838162,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,69,1 [0.97-1.03],0.909044407400392,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,69,1 [0.97-1.03],0.914372301619767,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,69,1 [0.97-1.03],0.915317965299701,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,69,1 [0.97-1.03],0.917396931599892,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL19,Interleukin-19,Inverse variance weighted,69,1 [0.98-1.03],0.91777993625669,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,69,1 [0.97-1.03],0.917914684841815,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD164,Sialomucin core protein 24,Inverse variance weighted,69,1 [0.98-1.03],0.920567145231206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,69,1 [0.97-1.03],0.921638035123016,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,69,1 [0.97-1.03],0.92306765320198,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SIAE,Sialate O-acetylesterase,Inverse variance weighted,69,1 [0.97-1.03],0.924499535116042,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,69,1 [0.97-1.03],0.926505032429936,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,OGN,Mimecan,Inverse variance weighted,69,1 [0.97-1.03],0.927121453882746,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,69,1 [0.97-1.03],0.929475897204352,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,69,1 [0.97-1.04],0.929741771405787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LGALS1,Galectin-1,Inverse variance weighted,69,1 [0.97-1.03],0.93056454037729,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MDK,Midkine,Inverse variance weighted,69,1 [0.97-1.03],0.930625811516245,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,F2R,Proteinase-activated receptor 1,Inverse variance weighted,69,1 [0.97-1.03],0.93132648954932,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PLSCR3,Phospholipid scramblase 3,Inverse variance weighted,69,1 [0.97-1.03],0.93399140002789,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,69,1 [0.97-1.03],0.934300771199553,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NGRN,Neugrin,Inverse variance weighted,69,1 [0.97-1.03],0.934786878059777,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LYPD8,Ly6/PLAUR domain-containing protein 8,Inverse variance weighted,69,1 [0.97-1.03],0.934862034698032,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PNLIP,Pancreatic triacylglycerol lipase,Inverse variance weighted,69,1 [0.96-1.04],0.936401402486473,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,XPNPEP2,Xaa-Pro aminopeptidase 2,Inverse variance weighted,69,1 [0.96-1.04],0.936442908092292,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CA12,Carbonic anhydrase 12,Inverse variance weighted,69,1 [0.96-1.04],0.93855782207696,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MAP2,Microtubule-associated protein 2,Inverse variance weighted,69,1 [0.98-1.03],0.93865215166237,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,69,1 [0.97-1.02],0.93953057367544,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Inverse variance weighted,69,1 [0.97-1.03],0.940087720701488,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,69,1 [0.98-1.03],0.940171623492999,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,69,1 [0.97-1.03],0.941929878140763,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IFNL1,Interferon lambda-1,Inverse variance weighted,69,1 [0.98-1.02],0.943955678575876,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CLSTN3,Calsyntenin-3,Inverse variance weighted,69,1 [0.97-1.02],0.945647828126294,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PON2,Serum paraoxonase/arylesterase 2,Inverse variance weighted,69,1 [0.98-1.02],0.951455654611195,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PPL,Periplakin,Inverse variance weighted,69,1 [0.97-1.03],0.951767530002043,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,69,1 [0.97-1.03],0.952201409498153,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BOC,Brother of CDO,Inverse variance weighted,69,1 [0.96-1.04],0.953917233412921,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GOT1,"Aspartate aminotransferase, cytoplasmic",Inverse variance weighted,69,1 [0.97-1.03],0.955659320757983,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,JAM3,Junctional adhesion molecule C,Inverse variance weighted,69,1 [0.97-1.03],0.956891805742387,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HRG,Histidine-rich glycoprotein,Inverse variance weighted,69,1 [0.97-1.03],0.95931949356062,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,MYDGF,Myeloid-derived growth factor,Inverse variance weighted,69,1 [0.97-1.03],0.959734994428281,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD7,T-cell antigen CD7,Inverse variance weighted,69,1 [0.98-1.03],0.96098871089651,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,AOC3,Membrane primary amine oxidase,Inverse variance weighted,69,1 [0.9-1.11],0.961327678602302,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CNTN5,Contactin-5,Inverse variance weighted,69,1 [0.97-1.03],0.963391507499746,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,69,1 [0.97-1.03],0.964299050177328,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,YES1,Tyrosine-protein kinase Yes,Inverse variance weighted,69,1 [0.97-1.03],0.964849686794993,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TGFBR1,TGF-beta receptor type-1,Inverse variance weighted,69,1 [0.98-1.02],0.967639880396055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,BAMBI,BMP and activin membrane-bound inhibitor homolog,Inverse variance weighted,69,1 [0.97-1.03],0.969102756902775,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,69,1 [0.97-1.03],0.96988262266868,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,LAT2,Linker for activation of T-cells family member 2,Inverse variance weighted,69,1 [0.97-1.03],0.970841903790188,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IL22,Interleukin-22,Inverse variance weighted,69,1 [0.97-1.03],0.971018443079473,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,SEMA3G,Semaphorin-3G,Inverse variance weighted,69,1 [0.97-1.03],0.97564006398478,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,NTF3,Neurotrophin-3,Inverse variance weighted,69,1 [0.97-1.03],0.976036395013862,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PTK7,Inactive tyrosine-protein kinase 7,Inverse variance weighted,69,1 [0.98-1.03],0.976817083081362,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,69,1 [0.98-1.03],0.977326923375766,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,69,1 [0.98-1.03],0.977465017603191,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,DKK1,Dickkopf-related protein 1,Inverse variance weighted,69,1 [0.97-1.03],0.97947761057577,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,PCYT2,Ethanolamine-phosphate cytidylyltransferase,Inverse variance weighted,69,1 [0.97-1.03],0.980334482815989,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,69,1 [0.97-1.03],0.981988831209024,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,69,1 [0.98-1.02],0.982249909554019,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,69,1 [0.97-1.03],0.982535615318815,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CFB,Complement factor B,Inverse variance weighted,69,1 [0.97-1.04],0.984301994429351,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CA6,Carbonic anhydrase 6,Inverse variance weighted,69,1 [0.97-1.03],0.984378374391804,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,69,1 [0.97-1.03],0.986418380452635,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,69,1 [0.97-1.03],0.987985471978867,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,STX4,Syntaxin-4,Inverse variance weighted,69,1 [0.97-1.03],0.992311933691388,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,APCS,Serum amyloid P-component,Inverse variance weighted,69,1 [0.96-1.05],0.99606779652329,trans
